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CHAPTER I

INTRODUCTION

Lectins have been used in a variety of biological assays to study
the surface structure and function of cells and tissues.

Lectins are

proteins that are highly specific in their saccharide binding
requirements as demonstrated by hapten inhibition studies where the
interactions between lectins and cell surface glycoconjugates can be
inhibited by simple sugars (Sharon and Lis, 1972).

In addition, many

lectins exhibit differential binding affinities for various mammalian
cells due to cell-specific differences in the expression of membrane
glycoconjugates.

These properties promote the use of lectins as

probes to study the structure and activity of cell surface components
in both normal and pathologically-altered tissues.

In biological

assays, lectins have been used to mimic the functional effects of
documented, physiological mediators of cellular activity, such as
hormones, lymphokines and vitamins.

Therefore, lectins have been used

as in vitro model systems to evaluate the mechanisms of cellular
activation and/or inhibition.
Although the biological effects of many lectins have been
investigated on a variety of cellular systems both.!.!!_ vivo and in
vitro, few studies have used lectins to evaluate the structure and
1
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function of the skeletal system.

The studies involving the skeletal

system {Wang et al., 1982; Horton et al., 1982; Ryder et al., 1982)
indicate that some lectins {i.e. PHA-P and con A) can induce changes
in the structure and function of bone cells, particularly osteoclasts.
The osteoclast is a large multinucleate cell that is widely accepted
as the primary effector cell responsible for normal bone resorption
{Marks, 1983).

Although the definitive origin of the osteoclast

remains uncertain, there is abundant evidence to support the
hypothesis that osteoclasts are derived from mononuclear cells of
hemopoietic origin, possibly of the monocytic lineage {Walker, 1975;
Marks and Walker, 1981; Schneider and Byrnes, 1983).
Bone-organ cultures of long bones or calvariae from neonatal
rodents are model systems used to study the morphological and
functional effects of biologically active mediators on osteoclastic
bone resorbing activity.

This type of culture system has the

advantage of correlating changes in morphology with altered functional
activity as compared to other culture systems in which the cells being
studied are not on their normal substrate.

Reynolds and Dingle {1970)

reported several advantages in using organ cultures of rodent
calvariae in comparison to organ cultures of long bones.

The

distribution and numbers of osteoclasts on the inner surface of the
flat bones of the growing rodent skull are well-documented {Barnicott,
1947; Abe et al., 1983; Jones and Boyde, 1976 Jones and Boyde, 1977).
The first part of this dissertation is designed to investigate

3

the biological effects of various lectins on bone resorption using a
calvarial culture system.

The remaining studies are designed to

evaluate possible mechanisms responsible for lectin-induced changes in
the ability of osteoclasts to resorb bone.

Concanavalin A {con A) is

the most widely used lectin in biological assays and many of its
properties have been well-documented and thoroughly investigated.
Other lectins that are frequently used to study the structure and
function of cells and tissues include wheat germ agglutinin {WGA).
soybean agglutinin (SBA) and peanut agglutinin (PNA).

The saccharide

binding specificities of these four lectins are distinctly different
from one another and the sugar residues to which these lectins bind
are common to mammalian membrane-associated glycoconjugates.
The four lectins. con A. WGA. SBA and PNA. were used in
conjunction with a

45

Ca pre-labeled calvarial-organ culture system to

assess their effects on bone resorption.

However. the primary

emphasis throughout this dissertation focuses on the lectin. con A.
In the first study. we treated osteoclasts and osteoblasts on the
endocranial surface of 10-day old rat calvariae with con A and
hemocyanin to determine whether or not specific con A binding sites
are present on these bone cell membranes as visualized by scanning
electron microscopy (SEM).

In addition. we conducted a series of

bone release assays using pre-labeled calvariae to evaluate the
effects of various concentrations of con A on the bone resorbing
capacity of osteoclasts.

After determining the con A-mediated

45

ca

4
effects, we were interested in the effects of the other 3 lectins,
WGA, SBA and PNA, on

45

Ca release in the calvarial culture system.

the second study, we conducted another series of

45

In

Ca bone release

assays using a lectin concentration of 50 pg/ml for each of the
lectins to be tested.

The 50 pg/ml lectin concentration was chosen on

the basis of the results obtained from the first study.
The third and fourth studies are designed to gain some insight
into the mechanisms that may be responsible for lectin induced changes
in bone resorption and osteoclastic function.

Because of the

difficulty in obtaining pure populations of osteoclasts, most studies
on bone resorption are performed on intact animals or bone-organ
cultures.

These systems do not permit detailed analysis of the

cellular mechanisms of bone resorption or of the means whereby
resorbing cells attach to the bone surface (Teitelbaum et al., 1979).
Since monocytes and macrophages are capable of attaching to and
subsequently degrading a bone matrix, the macrophage-devitalized bone
culture system serves as a useful model to study the mechanisms of
bone resorption in tissue culture.

(Kahn et al., 1978; Teitelbaum et

al., 1979; Bar-Shavit et al., 1983a).
In the third study, we used a macrophage-devitalized bone culture
system to evaluate the effects of 2 lectins, con A and SBA, on the
morphology of macrophage attaclunent to a devitalized bone surface and
the subsequent functional ability of these lectin-treated cells to
mobilize bone mineral.

SEM was used to assess the qualitative and
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quantitative differences in the attachment of macrophages to bone in
the presence and absence of lectin.

Furthermore,

45

Ca bone release

assays were conducted to evaluate the functional significance of the
morphological findings.
The induction of many of the functional effects by cell-specific
mediators of cellular activity (ligands) requires the internalization
of ligand-receptor complexes subsequent to the binding of a particular
ligand to specific membrane receptors.

The internalization of a

cell-bound ligand usually includes an initial redistribution followed
by endocytosis of the ligand-receptor complexes.

These

metabolically-dependent events have been studied in a variety of
substrate-attached mononuclear cell cultures.

Some studies have

employed the use of biologically active lectins conjugated to
ultrastructural and cytochemical marker molecules to follow the
movement of the lectin-receptor complexes both on the cell surface and
in the cytoplasm.

In the fourth study, we investigated the processing

of con A-receptor complexes by osteoclasts in culture.

Con A

conjugated to fluoresceinisothiocyanate (con A-FITC) was used to
evaluate the redistribution of cell-bound con A via epifluorescence
microscopy.

In addition, an ultrastructural study using con A-

ferritin was conducted to determine whether these lectin-receptor
complexes are

int~rnalized.

The endocytosis of lectin-receptor

complexes may represent a general mechanism that is used by
osteoclasts to process other endogenous physiological agents that bind

6

directly to the osteoclast membrane thereby regulating osteoclastic
activity.

CHAPTER II

REVIEW OF RELATED LITERATURE

Lectins - General Review
Lectins, the term proposed by Boyd in 1970, are proteins
possessing the ability to agglutinate red blood cells as well as a
variety of other cell types.

They are isolated from a wide variety of

sources, ranging from the seeds of plants to the horseshoe crab.
Besides their agglutinating ability, lectins exhibit a host of other
interesting biological properties (Lis & Sharon, 1973).

Some lectins

are specific in their reaction with human blood groups and are used in
the typing of human blood and to study the chemical structure of
substances defining blood groups.

Certain lectins are mitogenic; they

can stimulate the transformation of small resting lymphocytes into
large blast-like cells which undergo mitotic division.

This

polyclonal stimulation provides an important tool for examination of
the biochemical events involved in the conversion of a resting cell
into an active, dividing cell.

Lectins have also been used in

cytogenetics to study the relationships between chromosome abnormality
and human diseases.
Lectins bind to specific saccharides on the cell surface,
providing a useful tool to study cell surface architecture.

7

Lectins

8
specifically precipitate polysaccharides and glycoproteins, a property
useful in the isolation and purification of carbohydrate-containing
polymers (Sharon & Lis, 1972).

By virtue of their specific

interactions with polysaccharides and glycoproteins, they have served
as a useful model to study the antigen-antibody reaction.

There has

been a surge of interest in lectins among investigators engaged in
cancer research.

Some lectins, such as con A, WGA and SBA,

preferentially agglutinate transformed mammalian cells grown in tissue
culture, indicating that the cell surface of a transformed cell
differs significantly from the surface of its untransformed
counterpart (Inbar & Sachs, 1969a; Inbar & Sachs, 1969b; Burger &
Goldberg, 1967; Sela et al., 1970).

The use of lectins to inhibit the

growth of malignant cells in vivo and in vitro (Burger & Noonan, 1970;
Shoham et al., 1970), and the use of lectin-binding synthetic polymers
to immunize mice against various tumors (Shier, 1971), are examples of
the potential clinical usefulness of lectins in oncology.

Recently,

lectin histochemistry has been used in developmental biology to
evaluate changes in cell surface glycoconjugates during the
development of various tissues and organ systems (Wu et al., 1983; Lee
and Damjanov, 1984; Farnum and Wilsman, 1984; Wu et al., 1984).
Green et al. (1981) and Fleisher et al. (1981) have shown that
con A-activated peripheral blood mononuclear cells produce a soluble
immune suppressor supernatant (SISS) which contains certain factors
that are capable of suppressing immune responses in vitro.

Barrett et

9
al. {1983) reported that WGA could inhibit lymphocyte blastogenesis,
induced by a variety of mitogenic lectins.

Thus, WGA-mediated

inhibition of mitogenesis was found to mimic the suppressive effect of
SISS on lymphocyte blastogenesis.

They also demonstrated that the

inhibition of mitogenesis induced by either WGA or SISS could be
blocked by the addition of N-acetylgalactosamine, the specific sugar
inhibitor of WGA binding.

Furthermore, WGA and SISS compete with one

another for the same cell surface receptor site.

These findings

support the hypothesis that inhibitory or suppressive signals for
lymphocyte activation can be generated by the binding of soluble
saccharide-specific factors that interact with cell surface
glycoconjugates {Green et al., 1981; Fleisher et al., 1981).

A study

by Leu et al. {1980) compared a lectin, fucose binding protein {FBP),
with a lymphokine, migration inhibitory factor {MIF), for its binding
interactions with peritoneal macrophages using a migration inhibition
assay.

Their results demonstrated that both FBP and MIF inhibited the

migration of macrophages in similar dose-response profiles.

In

addition, L-fucose, the specific sugar inhibitor of FBP, blocked the
inhibitory effect of both FBP and MIF on macrophage migration.

-

Therefore, the interaction of exogenous lectins or endogenous
lymphokines with saccharide-associated cell surface receptors may
represent a common mechanism by which soluble factors regulate
innunological responses.

All of these studies provide evidence to

substantiate the use of certain lectins as in vitro models for

10
saccharide-specific, biologically relevant mediators of cellular
activity.

This conclusion lends some additional credibility to the

possibility that lectin-induced changes in cellular morphology and
function, may mimic the effects of well-documented, physiological
agents that regulate the strucutre and function of cells in vivo.
The study of lectins was initiated by Stillmark in 1888, when he
described the agglutination of erythrocytes by plant extracts.

He

found that castor beans contained a toxic protein, which he named
ricin, capable of agglutinating both human and animal red blood cells.
Ehrlich used ricin to study and describe a fundamental principle of
immunology.

In 1891, he reported that mice could be immunized against

a lethal dose of ricin by repeated subcutaneous injections of minute
amounts of the toxin, and that the serum of these immunized mice was
capable of neutralizing the toxin.

In 1908, Landsteiner and

Raubitschek demonstrated that various seed extracts exhibited
differential agglutinating activities when tested with erythrocytes
from different animals, and they compared this specificity with that
of animal serum antibodies.

Although it was originally presumed that

plant hemagglutinins were non-specific with respect to blood groups,
these initial observations by Landsteiner and Raubitschek (1908) led
to the discovery that certain lectins are specific for one or more
human blood group antigens (Boyd & Reguera, 1949).
Most of the initial studies using lectins were conducted using
crude extracts of plant origin.

Although the first purified lectin,
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concanavalin A, was obtained in crystalline form from the jack bean by
Sumner as early as 19i9, it was not until 1936 that Sumner and Howell
showed that purified con A agglutinated horse red blood cells at
concentrations as low as O.l_µg/ml, thus linking the agglutinating
activity of the jack bean extract with con A.

Since then, con A has

become the most widely used lectin in biological assays.

Other

lectins which have been widely used to study the structure and
function of various cellular systems include WGA, SBA and, more
recently, PNA.

These three lectins have also been isolated in

purified form and their chemical composition determined.
Lectins are highly specific in their cell surface saccharide
binding requirements.

This conclusion is based on hapten inhibition

studies which demonstrate that the interactions of lectins with cells
can be specifically inhibited by simple sugars.

Some lectins

discriminate between 0(- and ~-anomers of a particular sugar residue,
while others bind to both the d..- and ~-anomeric structures with equal
affinity.

Some lectins require that the binding sugar be located in a

terminal non-reducing position in the oligosaccharide chain, while
others can bind to sugars within the oligosaccharide chain.

The

affinity between a lectin and its binding site can exhibit a great
deal of variation due to small changes in the sequence of sugars
within an oligosaccharide.

Because of the binding specificity that

each lectin has for a particular carbohydrate structure, even
oligosaccharides with identical sugar compositions can be separated

12
and distinguished from one another.
Most lectins that have been isolated and analyzed to date are
composed of multiple subunits, which are held together by non-covalent
bonds.

These subunits are polypeptide chains that usually contain

covalently bound carbohydrate side chains.

Con A, WGA, SBA and PNA

are multimeric lectins; con A and PNA are each composed of 4 identical
subunits, whereas WGA and SBA are each composed of 2 identical
subunits.

SBA and PNA are glycoproteins, and the sugars which have

been isolated from these lectins are common to animal cell membranes.
In contrast, con A and WGA are devoid of covalently bound carbohydrate
side chains.

It is the multimeric structure of lectins that allows

them to agglutinate cells and form precipitates with glycoconjugates
in a manner similar to antigen-antibody interactions.

Although most

lectins can bind to a variety of different cell types, agglutination
of cells occurs only in some cell types.

On the other hand, some

lectins do not bind to particular cell types, which is probably due to
the absence or masking of the suitable receptor oligosaccharides on
the cell surface.
The sugar specificities of con A, WGA, SBA and PNA are distinctly
different from one another.

All of the sugar residues to which these

lectins bind are common to many mammalian membrane-associated
glycoconjugates.

Con A has a broad biological applicability primarily

because it recognizes 2 commonly occurring cell surface saccharides,
o(-D-mannose and D<-D-glucose.

Although it was originally postulated

13
that the specificity of con A is directed toward a single sugar
residue, studies by So et al. (1968) demonstrated that o(-linked
mannose disaccharides and trisaccharides are stronger inhibitors of
the con A-dextran interaction by 5 and 20 times respectively, than is
~-methylmannoside,

the haptenic sugar inhibitor of con A binding.

These results suggest that the con A binding site is more complex in
both its primary structure and three-dimensional configuration than
originally proposed.

WGA can bind oligosaccharides containing

terminal N-acetylglucosamine (GluNAc) residues, with preferential
binding to dimers and trimers of this saccharide.

SBA preferentially

binds to oligosaccharides with terminal ~- or P-linked
N-acetylgalactosamine (GalNAc) residues, and to a lesser extent to
D-galactose residues.

PNA binding is directed toward D-galactose

residues, although this lectin binds to the disaccharide, galactosyl

G-1,3 GalNAc, with greatest affinity.

This dissacharide is called the

T-antigen, and its presence on the surface of human erythrocytes is
responsible for a phenomenon known as T-polyagglutination, a problem
encountered in routine serology.

T-polyagglutination, the

agglutination of red blood cells irrespective of blood type, is caused
as a result of in vitro contamination of blood specimens by the
degradative action of bacterial neuraminidase which exposes the
T determinant (Goldstein & Hayes, 1978).

The discovery of PNA has

greatly simplified the determination of T-polyagglutination in blood
specimens.

14

processing of Concanavalin A
Since con A is the most widely used lectin in biological assays,
it has been used extensively as a probe to study cell surface
interactions.

The various biological activities of con A all appear

to involve initial binding of con A to the cell surface.

The manner

in which cells process this cell-bound lectin has been the focus of a
great number of investigations.

Although various cell types have been

used in these studies, most of the observations have been made using
lymphocytes, since it is well documented that con A is mitogenic for
lymphocytes.

Taylor et al. (1971) demonstrated cap formation of

surface immunoglobulin (lg) determinants on mouse lymphocytes induced
by the interaction of FITC-labeled anti-lg antibodies with the lg
molecules of the cell membrane.
determinants were pinocytosed.

Following capping, the surface lg
Since this initial discovery,

antibody-induced patch and cap formation has been described in various
cell types.

In 1972, Yahara and Edelman reported that con A prevents

anti-lg patch and cap formation, presumably by restricting the
mobility of cell surface lg determinants.

Karnovsky and Unanue (1973)

reported that the redistribution of con A receptors, induced by the
binding of con A, did not alter the distribution of surface lg
molecules and vice versa.

These findings indicate that the inhibition

of patching and capping by con A cannot be attributed to the linkage
of mobile receptors to immobile con A receptors by con A, nor to
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extensive cross-linkage of various specific receptors by con A.
Gunther et al. (1973) observed that divalent succinylated con A cannot
inhibit receptor mobility although it directly competes with its
non-derivatized counterpart for the same binding sites.

These

observations suggest that the binding valency of the lectin is an
important factor in the inhibition of receptor mobility and the
cross-linkage of receptor molecules is a necessary condition for
inhibition of receptor mobility.
In contrast to its inhibitory effects on patch and cap formation,
con A has been shown/to induce patching and capping of its own binding
Unanue et al. (1972)

sites under certain conditions of incubation.

used FITC-con A to demonstrate that patching and capping of con A
binding sites occurred when lymphocytes were labeled with con A at
0

4 C, then washed to remove unattached con A molecules, followed by
incubation at 37°c.

Yahara and Edelman (1973) showed that lymphocytes

incubated at 37°c in concentrations of con A above 10 )Jg/ml did not
exhibit patch or cap formation, whereas at concentrations below

10 pg/ml capping of con A binding sites occurred in a small percentage
of cells.

In contrast to the findings observed at 37°c, when
0

lymphocytes were pre-incubated with con A at 4 C, then washed to
0

remove excess con A and incubated at 37 C, patch and cap formation was
observed in a large percentage of lymphocytes regardless of the
concentration of con A.

These observations were confirmed by Bhalla

et al. (1979) who demonstrated that if washing is omitted after
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pre-incubation at 4 C or if con A is added again after washing, the
0

percentage of cells forming caps at 37 C is drastically reduced.
These results indicate that depending on the conditions of incubation
employed, con A exhibits 2 antagonistic properties when bound to
lymphocytes.

Con A exhibits the ability to induce cap formation of

its own binding sites and it can also inhibit the redistribution of
ligand-receptor complexes including that of its own.
Since it has been postulated that some of the biological effects
of con A initiated at the cell surface may be a result of its multiple
binding valency, it is necessary to compare the effects of different
forms of this molecule, each having the same binding specificity but
different valence.

Wang and Edelman (1978) reported the preparation

and characterization of monovalent, divalent and tetravalent con A
molecules that are stable at physiological pH.

They demonstrated that

all three derivatives were potent mitogens for mouse splenic
lymphocytes suggesting that multipoint attachment and cell surface
receptor bridging are not necessary for lymphocyte activation.

In

contrast, at concentrations above the mitogenic optimum, only
tetravalent con A was capable of inhibiting both cap formation and
cell proliferation.

These results indicate that the inhibition of

binding site mobility and DNA synthesis does require extensive
cross-linkage of con A binding sites.

The observations made in this

study can explain the inconsistent observations of Greaves et al.
(1972) and Sallstrom et al. (1972), who reported that a large
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0

percentage of lymphocytes incubated at 37 C in high concentrations of
con A exhibited patch and cap formation.

It has been shown that the

fluorescein-labeled con A molecules used by these investigators were
irreversibly denatured, and therefore, these molecules were either
monovalent or divalent derivatives.

The observations that con A can

bind to various molecules that do not contain any saccharide residues
in their structure led to the identification of a hydrophobic binding
site within the con A molecule that is distinct from and independent
of its saccharide binding site (Edelman & Wang, 1978).

After con A

binds to the cell surface via its saccharide binding site it is
capable of interacting with hydrophobic ligands; this secondary
interaction may induce surface alterations necessary for some of the
biological effects mediated by this lectin.
Although cross-linkage of receptor sites can partially account
for the ability of con A to inhibit the redistribution of
ligand-receptor complexes including that of its own, this event does
not account for the difference in the number of cap forming cells
0

following pre-incubation at 4 C as compared to cells incubated at
37°C.

It is well known that antimitotic agents, such as colchicine

and vinblastine, or incubation in cold (4°C) will cause the disruption
of microtubules.

Numerous studies have demonstrated that microtubule

disassembly is directly correlated with enhanced con A cap formation
on lymphocytes and other cell types (Edelman et al., 1973; Unanue &
Karnovsky, 1974; Oliver, 1976; Bhalla et al., 1979; Oliver et al.,
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19 so).

These observations suggest a role for microtubules in limiting

the lateral movement of con A-binding site complexes within the
membrane.

Edelmen et al. (1973) have proposed an hypothesis that

relates con A-mediated cell surface events to colchicine-sensitive
binding proteins (CBP) in the cytoplasm.

These proteins may either be

the components of microtubules or be closely related to micotubular
proteins.

They suggest that con A binding sites may occur in 2

states; free (not attached to CBP) or attached (anchored to CBP).
Thus, the treatment of cells with an agent that disrupts microtubules
allows greater mobility because the equilibrium between these two
receptor states shifts greatly in favor of the free receptors.

This

hypothesis provides an explanation for the increase in con A-induced
0

cap formation observed when cells are pre-labeled at 4 C or treated
with a microtubular poison.
Microfilaments have also been implicated in lectin-mediated cell
surface activation.

Studies have demonstrated that the aggregation of

con A-binding site complexes into caps can be prevented by metabolic
inhibitors and by agents, such as cytochalasin B, that impair
microfilament function (Ryan et al., 1974; dePetris, 1975; Schreiner &
Unanue, 1976).

Condeelis (1979) isolated con A cap-associated

membrane fragments at various stages of formation and demonstrated a
submembranous network of microfilaments in association with these
capped membrane fragments.

These studies support the hypothesis that

con A patch and cap formation depends on active contractile movements
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of microfilaments.

Although con A caps are underlain by a dense

network of microfilaments in lymphocytes and other cell types,
Albertini et al. (1977) demonstrated that the accumulation of
microfilaments in the region of the eventual site of con A cap
formation is not induced by con A.

Instead, they showed that the

accumulation of microfilaments follows the disruption of microtubules.
Their results indicate that the aggregation of microfilaments and
con A cap formation are independent events.

Once the cap is formed,

interactions between con A-binding site complexes and microfilaments
appear to stabilize the localization of both the surface-bound lectin
and the submembranous network of microfilaments.

The subsequent

internalization of con A-binding site complexes is a metabolically
dependent event (Smith & Hollers, 1970), and it is believed that the
interaction between surface-bound lectin and underlying microfilaments
is necessary for the endocytosis of these complexes.

Once con A has

been internalized there are several possible mechanisms by which the
lectin can mediate some of its biological effects.

Biological Effects of Lectins on the Skeletal System
The great number of studies examining con A binding and
subsequent processing by lymphocytes have provided hypotheses that
attempt to explain the mechanisms by which lectins interact with cell
surfaces, thereby altering the structure and activity of membrane
components.

Aside from the mechanisms which account for lectin-cell
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surface interactions, the biological effects of many lectins on a
variety of cellular systems have been investigated both in vivo and in
vitro.

However, only a few studies have used lectins as probes to

~

investigate their effects on the structure and function of the
skeletal system.

Wang et al. (1982) studied the effects of PHA-P, a

mitogen known to selectively stimulate cells of hematogenous or
lymphoid monocytic origin, on bone of the growing rat.

They

demonstrated that the in vivo administration of PHA-P for 15 days
caused a reduction in the number of osteoblasts, whereas the number of
osteoclasts, the number of

3

H-labeled osteoclastic nuclei and the

average number of nuclei per osteoclast were all significantly
increased.

They suggest that the increase in the number and size of

osteoclasts following in vivo administration of PHA-P is caused by
PHA-P induced osteoclast progenitor cell proliferation and the
enhanced fusion and differentiation of these progenitor cells into
osteoclasts.

Horton et al. (1982) in their

45

Ca bone release assays,

demonstrated a decrease in resorption of long bones cultured in the
presence of high concentrations of con A (50 & 100 µg/ml).

Subsequent

TEM of osteoclasts incubated in 50 µg/ml con A revealed
ultrastructural changes associated with inhibition of osteoclastic
activity (Ryder et al., 1982).
The studies involving the skeletal system indicate that some
lectins can induce changes in the structure and function of bone
cells, particularly osteoclasts.

Thus, lectins may prove to be useful
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probes to study changes in osteoclast morphology in relation to
changes in their bone resorbing activity.

Organ culture of calvaria

provides an ideal system for studying the effects of lectins on the
structure and function of resident osteoclasts on their normal
substrate.

The endosteal surface represents an easily accessible site

to study cell surface receptors on osteoclasts as well as changes in
osteoclast morphology as visualized by both SEM and TEM.

SEM can be

used to study changes in cell surface morphology, whereas TEM can be
used to investigate both surface and cytoplasmic changes within the
osteoclast.

Calvaria pre-labeled with

45

Ca can be used to study the

effects of lectins on bone resorption in vitro.

Biology of the Osteoclast
The osteoclast is a large multinucleate cell that is widely
accepted as the primary effector cell responsible for bone resorption
(Marks, 1983).

Ultrastructural changes associated with hormonal

regulation of osteoclastic activity have been well documented both in
vivo (Holtrop et al., 1979) and in vitro (King et al., 1978; Wezeman
et al., 1979).

Recently, various morphological changes of inhibited

osteoclasts cultured in the presence of calcitonin and prostacyclin
have been described using phase contrast microscopy (Chambers & Dunn,
1982; Chambers & Magnus, 1982; Chambers & Moore, 1983).

Similarly,

morphological characteristics of presumably active or inhibited
osteoclasts, as visualized by SEM, have been described both in situ
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(Jones & Boyde, 1977)

and~

vitro (Allen et al., 1981).

Despite all

of the observed morphological changes associated with various known
mediators of osteoclastic activity, little is known about the
mechanisms by which these hormones exert their effects.
Recently, numerous investigators have probed the osteoclast
membrane to determine whether or not specific receptors for
parathyroid hormone (PTH) and calcitonin (CT), the two primary
hormones regulating osteoclastic function, are present.
study utilizing

125

In an in vivo

I-calcitonin, localization of calcitonin receptors

on the osteoclast membrane has been demonstrated (Warshawsky et al.,
1980).

Calcitonin receptors have also been demonstrated on

osteoclasts by immunohistochemical staining (Rao et al., 1981).
Chambers and Magnus (1982) confirmed the localization of CT receptors
on osteoclasts by demonstrating that calcitonin causes complete
inhibition of cytoplasmic motility in isolated osteoclasts in vitro.
In contrast, light microscopic autoradiographs of chick embryonic
calvaria after exposure to

125

I-parathyroid hormone (PTH; 1-34) have

revealed PTH receptors on osteoblasts, but not osteoclasts (Silve et
al., 1982).

The lack of PTH receptors on osteoclasts is also

supported by the recent findings of Chambers and Dunn (1982); the
addition of PTH to cultures of isolated osteoclasts caused no change
in their behavior or morphology.

Similarly, PTH added to isolated

osteoclasts that were previously inhibited by CT did not oppose the
morphological inhibitory changes induced by calcitonin (Chambers &
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Moore, 1983).

These results support the hypothesis that some hormones

may act directly on osteoclasts (i.e. CT), while others may regulate
osteoclastic activity indirectly (i.e. PTH) through the intermediary
of another cell type (Chambers & Dunn, 1983).
Besides PTH and CT, several studies have identified other
hormones and biologically active molecules that can mediate bone
resorption in vitro.

The mechanism by which mitogenic lectins

stimulate lymphocyte production of osteoclast activating factor (OAF)
has been well documented (Horton et al., 1972; Horton et al., 1974;
Trummel et al., 1975; Yoneda et al., 1979).

Horton et al. (1974)

showed that OAF production by lymphocytes depends on an interaction
between macrophages and lymphocytes.

The release of OAF by

lymphocytes stimulates osteoclastic activity resulting in an increased
resorption of bone.

Gowen et al. (1983) demonstrated that the

monokine, interleukin 1, stimulates bone resorption in vitro.

Klein

and Raisz (1970) demonstrated that the effects of several
prostaglandins on bone resorption were similar to those of PTH in
stimulating the resorption of fetal long bones in vitro.
Raisz et al. showed that

l~,25

dihydroxyvitamin n
3

In 1972,

(l~,25(0H) n )

2 3

potent stimulator for the release of previously incorporated
fetal long bones in culture.

45

is a

ca from

Nimberg et al. (1981) recently purified

and characterized a glycoprotein from cancer ascites fluid which
stimulates the resorption of bone explants in vitro.

These findings

suggest that the localized osteolysis seen in patients with a wide
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variety of neoplasms may be mediated by bone-resorbing humoral
factors.

Chambers and Dunn (1983) showed that the addition of PGE

l~,25(0H) n

2 3

2

or

to cultures of isolated osteoclasts caused no change in

their behavior or morphology.

Since numerous investigators have

observed that prostaglandins and l«,25(0H) n have a variety of
2 3
effects on osteoblasts, a role for osteoblasts in the hormonal control
of bone resorption has been postulated (Rodan & Martin, 1981).
The hypothesis that the osteoclast precursor is extraskeletal in
origin has been recently accepted (Marks, 1983).

Although the

definitive origin of the osteoclast remains uncertain, there is
abundant evidence to support the hypothesis that osteoclasts are
derived from mononuclear cells of hemopoietic origin, possibly of the
monocytic lineage (Walker, 1975; Harks and Walker, 1981; Schneider and
Byrnes, 1983).

This hypothesis has created an extensive investigation

to determine if these 2 distinct cell types share a common lineage.
Studies have focused on both structural and functional similarities
between these two cell types.
Some investigators have studied the cell surface of both
osteoclasts and macrophage mononuclear cells to determine whether or
not certain receptor sites known to exist on macrophages can also be
demonstrated on osteoclasts and vice versa.

The findings of one study

supporting the presence of common membrane determinants in these two
cell types, indicated that elicited peritoneal mononuclear phagocytes
possess functional receptors for both PTH and CT (Minkin et al.,
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197 7).

In contrast, although Fe and C3 receptors are normally present

on macrophages, no one has been able to demonstrate these receptors on
osteoclasts either in situ (Shapiro et al., 1979; Hogg et al., 1979)
or_!!!. vitro (Chambers, 1979).

Other studies have focused on

functional similarities between the osteoclast and the macrophage
mononuclear cell.

Martini et al. (1982) used an in vitro assay to

quantitate the attachment of osteoclasts and monocytes to developing
bone.

Their results demonstrated that twice as many osteoclasts and

monocytes adhere to bone as compared to fibroblasts or mesenchymal
cells.

These observations suggest that osteoclasts and monocytes have

a higher affinity for bone than cells that are unrelated to a bone
substrate.

Zallone et al. (1983) demonstrated that osteoclasts and

monocytes exhibit similarities in their intracellular organization of
cytoskeletal elements and adhesive properties in vitro.

Macrophage Mediated Bone Degradation
In addition to the many studies which have attempted to establish
a common lineage between the osteoclast and the macrophage mononuclear
cell, it has been well-documented that cells of the mononuclear
phagocyte system are capable of resorbing devitalized bone in vitro
(Mundy et al., 1977; Kahn et al., 1978; Teitelbaum et al., 1979).
Kahn et al. (1978) demonstrated that peripheral blood monocytes are
capable of resorbing devitalized bone in culture and that an important
component of this process involves the attachment of the monocytes to
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the bone matrix.

Teitelbaum et al. (1979) developed an experimental

system in which bone resorption by mononuclear cells can be precisely
quantitated via the release of either
pre-labeled bone.

3

H-proline or

45

Ca from

Their results also indicated that optimal

mobilization of the radioactive label by mononuclear cells requires
cell-matrix contact.

In contrast to these findings, Mundy et al.

(1977) reported that physical contact between peripheral blood
monocytes and bone in tissue culture was not a necessary condition for
the release of bone mineral and matrix.
Glowacki et al. (1981) recently developed a model system in which
they implanted devitalized bone fragments into calvarial defects in
rats.

These implants initiated a rapid cell-mediated resorptive

sequence.

A histological and ultrastructural study of these implants

by Holtrop et al. (1982) demonstrated that the cells surrounding the
bone fragments belong to the mononuclear phagocyte system.

However,

none of these cells, even the multinucleate giant cells, had ruffled
borders, a morphological hallmark of osteoclasts, and therefore, could
not be classified as osteoclasts.

Other studies have also

demonstrated that macrophages attached to bone acquire a number of the
morphological characteristics of osteoclasts in culture, with the
exception of ruffled borders (Kahn et al., 1978; Rifkin et al., 1979).
Severson (1983) took mononuclear cells isolated from the spleen or
bone marrow of young rats and injected them into diffusion chambers
containing devitalized bone fragments.

She reported that these

27
mononuclear cells differentiated into osteoclast-like cells as
visualized by light microscopy (LH) and SEM.

All of these

observations support the hypothesis that bone resorption in vivo
involves the participation of macrophages in conjunction with the
action of osteoclasts (Heersche, 1978).
Since the degradation of mineralized bone matrix .!E_ vivo is
primarily a function of mutinucleated osteoclasts which are derived
from mononuclear precursors, investigators have studied whether or not
the attainment of the multinucleated state has any effect on the
ability to attach to bone and subsequently degrade this matrix.

The

fusion of macrophages in vitro has been induced by treating macrophage
cultures with conditioned media obtained from con A-stimulated
lymphocytes (Sone et al., 1981) and from spleen cell cultures treated
with PHA, con A or l-<,25(0H) n (Abe et al., 1983).
2 3
l~,25(0H) n

2 3

fusion.

In addition,

added directly to macrophage cultures will also induce

Bar-Shavit et al. (1983a) showed that laC,25(0H) D elicits
2 3

monocytic differentiation and multinucleation in human promyelocytic
leukemia HL-60 cells, and that this transformation is accompanied by a
marked increase in the ability of these cells to bind and resorb bone.
Fallon et al. (1983) produced macrophage polykaryons by exposing
elicited macrophages to human serum.

These macrophage polykaryons and

their mononuclear precursors were assessed for their ability to
degrade

45

ca-labeled, devitalized bone in vitro.

The results

demonstrate that macrophage polykaryons exhibit a greater resorptive
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potential suggesting that the formation of multinucleated cells from
mononuclear precursors is a physiologically significant event.

CHAPTER III
ULTRASTRUCTURAL LOCALIZATION OF CONCANAVALIN-A
BINDING SITES ON BONE CELLS: EFFECTS OF
CON A ON OSTEOCLASTIC BONE RESORPTION

29
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ABSTRACT

When osteoclasts on the endocranial surface of 10-day old rat
calvaria are treated with concanavalin-A and hemocyanin, con A binding
sites can be visualized by scanning electron microscopy {SEM).

The

hemocyanin label was uniformly distributed on the dorsal {unapposed)
surface of all osteoclasts observed by SEM; it could be visualized on
smooth surfaces, microvillous projections and filopodia.

Osteoblasts

were also labeled with the hemocyanin marker, demonstrating con A
binding sites.

45

ca bone release assays of prelabeled calvaria

incubated in varying concentrations of con A were conducted to
determine whether or not con A has any functional effects on
osteoclasts.

At low concentrations of con A {0.1 pg/ml), there was an

increase in bone resorption at 24, 48 and 72 hours of incubation.

In

contrast, calvaria incubated in high concentrations of con A {50 pg/ml
and 100 pg/ml) showed a marked decrease in bone resorption
significantly different from that of controls {incubated without the
addition of con A) at each of the three 24 hour time periods.
differences in the release of

45

These

Ca may indicate direct, dose-dependent

effects of con A on osteoclastic bone resorption.
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INTRODUCTION

The osteoclast is a large multinucleate cell which is widely
accepted as the primary effector cell responsible for bone resorption.
Although the ultrastructural changes associated with various hormones
which regulate osteoclastic activity have been well documented
(Wezeman et al., 1979; Holtrop et al., 1979), little is known about
the mechanisms by which these hormones exert their effect.

Recently,

investigators have probed the osteoclastic membrane to determine
whether or not specific receptors for parathyroid hormone (PTH) and
calcitonin (CT), the two primary hormones regulating osteoclastic
function, are present.

The results suggest that some hormones may act

directly on osteoclasts (i.e. CT), while others may regulate
osteoclastic activity indirectly (i.e. PTH) through the intermediary
of another cell type (Warshawsky et al., 1980; Rao et al., 1981; Silve
et al., 1982; Chambers and Dunn, 1982).
The hypothesis that the osteoclast precursor is extraskeletal in
origin has been recently accepted (Marks, 1983).

Although the

definitive origin of the osteoclast remains uncertain, there is
abundant evidence to support the hypothesis that osteoclasts are
derived from mononuclear phagocytes {Marks, 1983).

Some of the

studies to determine whether the osteoclast and the macrophage share a
common lineage have focused on the similarities and differences of
cell surface receptors on these two distinct cell types.

Recently,
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attempts to demonstrate Fe and C3 receptor sites on osteoclasts, which
are characteristically present on macrophages, have been unsuccessful
(Shapiro et al., 1979; Chambers, 1979; Hogg et al., 1980).
In addition to studies dealing with highly specific receptors,
lectins have been used as a more general probe to study both cell
surface characteristics and functions.

Horton et al. (1982) in their

45 ca bone release assays, demonstrated a decrease in resorption of
long bones cultured in the presence of high concentrations of con A
(50 pg/ml and 100 pg/ml).
(TEM)

Subsequent transmission electron microscopy

of osteoclasts incubated in 50 pg/ml con A revealed

ultrastuctural changes associated with inhibition of osteoclastic
acitivity (Ryder et al., 1982).

We therefore treated osteoclasts on

the inner surface of 10-day old rat calvaria with con A and hemocyanin
to determine whether or not specific con A binding sites were present
on the osteoclast membrane.

Furthermore, we incubated

45

Ca prelabeled

calvaria in varying concentrations of con A to evaluate the functional
significance of our morphological findings which verified the
existence of specific con A binding sites on osteoclasts.
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MATERIALS & METHODS

Cell Surface Labeling
Removal of Calvaria - Twelve 10-day old Norway Hooded rats were
anesthetized with ether and sacrificed prior to removal of their
calvaria.

The calvaria were incubated in Hanks' Balanced Salt

Solution (HBSS) for 30 minutes.

The soft tissue was dissected off the

endocranial surface and the calvaria were rinsed twice in phosphate
buffered saline (PBS).

Eight calvaria were used for

concanavalin-A-hemocyanin labeling and four were prepared for a
conventional SEM image.
Concanavalin-A-Hemocyanin Labeling - The labeling procedure
employed was similar to that used by Schneider et al. (1979) for
lymphocytes.

Eight calvaria were pre-fixed in 1.0% glutaraldehyde in

O.lM Na cacodylate buffer.

The samples were incubated in O.lM
0

ammonium chloride in cacodylate for 8 hours at 4 C, which blocks any
aldehydes on the cell surface that may cause non-specific hemocyanin
labeling.

The calvaria were then rinsed in cacodylate buffer and

incubated in 100 pg/ml concanavalin-A (con A) (Polysciences,
0

Warrington, Pa.) for 10 minutes at 37 C.
tetravalent form of con A.

This is the natural

In all of the following studies it was

used under the appropriate pH and ionic conditions to remain in its
tetravalent form.

After the con A treatment, one half of the calvaria

were incubated in 0.05M «-methyl mannoside (Polysciences, Warrington,
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pa.), a haptenic inhibitor of con A binding, and used as controls to
demonstrate the specificity of hemocyanin labeling.

Both con A

treated and control calvaria were then rinsed and incubated in
1.0 mg/ml hemocyanin (Polysciences, Warrington, Pa.) for 10 minutes at
37°c, followed by another rinse in cacodylate buffer.

The hemocyanin

was first passed through a 0.45 pm Millipore filter to avoid
aggregates which can obscure cell surface morphology.
Conventional SEM Tissue Preparation - After the labeling
procedure, all twelve calvaria were incubated in 2.5% glutaraldehyde
in O.lM cacodylate for l hour and post-fixed in 1.0% osmium tetroxide
in O.lM cacodylate for l hour at 4°C.

Following fixation the calvaria

were rinsed in cacodylate and dehydrated through a graded series of
ethanol.

They were then critical point dried via co

DCP-1 (Denton Vacuum, Cherry Hill, N.J.).

2

using a Denton

After drying, the specimens

• thickness) with
were attached to aluminum stubs and coated (200A
Gold/Palladium using a Hummer II sputter-coating apparatus (Technics,
Alexandria, Va.).

The specimens were scanned using an ETEC Autoscan

(Hayward, Ca.) at an accelerating voltage of 20kV and a 45

0

tilt.

~a Bone Release Assay
The calvaria of twelve 7-day old Norway Hooded rats were
pre-labeled by injecting the animals with 40 µCi of

45

ca per rat

(specific activity 10-40 mCi/mg calcium, Amersham, Arlington Heights,
Il.).

Three days later, the animals were anesthetized with ether and
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sacrificed.

The calvaria were removed under sterile conditions and

placed into HBSS.

The dura mater and periosteum were dissected off

the endocranial surface and the calvaria were rinsed in HBSS.

Each

calvarium was split longitudinally down the sagittal suture, and
corresponding halves were placed into adjacent wells of a 24-well
costar tissue culture cluster.

Each well contained 2 ml of BGJb media

supplemented with 5% Fetal Bovine Serum, 100 units/ml PenicillinStreptomycin, and 0.292 mg/ml Glutamine.
incubated at 37°C for 24 hours in 5% co
45 ca.

The calvarial halves were

2

and air to remove the labile

After 24 hours, the media was discarded and the wells were

rinsed with HBSS to remove any residual

45

Ca.

At this point, the calvarial samples were divided into 4 groups,
each containing 3 matching calvarial halves.

One half of each

particular calvarium was incubated in 2 ml of a specific concentration
of con A in supplemented BGJb media while the other half was incubated
in 2 ml of supplemented BGJb medial without the addition of any con A
and used as an internal control.

The concentrations of con A used in

this study were 0.1 pg/ml, 2.0 pg/ml, 50 pg/ml and 100 pg/ml.

At 24,

48, and 72 hours, 0.2 ml samples of culture media were pipetted off
each well and added to 10 ml Biocount liquid scintillation counting
cocktail (Research Products International, Mount Prospect, 11.).
Duplicate samples were taken from each well and the remaining media
was discarded at 24 and 48 hours.

Each well was rinsed with HBSS and

replenished with 2 ml of fresh media.

The cultures were terminated at
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1

2 hours.

All samples were counted in a Beckman LS 7000 Liquid

Scintillation System.
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RESULTS

Osteoclasts sequentially treated with concanavalin-A and
bemocyanin, were labeled with the hemocyanin marker molecule as
visualized by scanning electron microscopy (SEM).

Con A is a

tetravalent lectin which has a high affinity for ci('-D-glucosyl and
~-D-mannosyl

residues associated with membrane macromolecules, such as

glycoproteins, glycolipids and polysaccharides.

In the labeling

procedure employed in this study, the cell-bound lectin was visualized
by hemocyanin, a cylindrical-shaped marker molecule.

Hemocyanin is a

glycoprotein molecule possessing saccharide side chains which can
interact with free sugar binding sites on the con A molecule,
indicating the site of con A binding.

The dorsal (unapposed) surface

of all osteoclasts observed by SEM was uniformly labeled (figs. 1 and
2).

The hemocyanin label could be visualized on smooth surfaces,

microvillous projections and filopodia (figs. 2, 3 and 4).
Osteoblasts were also labeled with hemocyanin demonstrating con A
binding sites (figs. 5 and 6).

The possiblity of non-specific

hemocyanin labeling was eliminated by treating calvaria with -<-methyl
mannoside, a specific sugar inhibitor of con A binding.

None of the

resident bone cells on the endocranial surface of the calvaria treated
with o<-methyl mannoside and subsequently with hemocyanin were labeled
with the hemocyanin marker (figs. 7, 8, 9 and 10).

These cells were

indistinguishable from those observed on the calvaria which were
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conventionally prepared for SEM.

Therefore, the hemocyanin label was

specific for con A binding sites on the outer surface of the cell
membrane of both osteoclasts and osteoblasts.
The morphological findings presented indicate that osteoclasts
have binding sites for con A on their surface.

The 45 ca bone release

assays were conducted to determine whether or not con A, at various
concentrations, had any functional effect on osteoclasts.

The ability

of osteoclasts to resorb bone was determined by the amount of 45 ca
released to the tissue culture media during three 24 hour time periods
after the release of labile 45 ca.

Values for the level of

radioactivity (cpm) were obtained by counting duplicate samples from
each well at each time period.

The mean value (cpm) for each

calvarial half incubated in a specified concentration of con A was
divided by the mean value of the corresponding half incubated in
control media (no con A added) to give a treated/control (T/C) ratio
for each calvarium.

The mean T/C ratio for each of the four

experimental groups was calculated and compared to the mean
control/control (C/C) ratio for that same experimental group to
determine whether the observed changes in bone resorption were
significantly different.

Significance was evaluated by a two-tailed

Student t-test for the difference between two means.

The counts per

minute of any given duplicate sample never differed by more than 3%.
In samples incubated in 100 pg/ml con A, the concentration
utilized for the morphological studies, there was a marked decrease in
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bone resorption apparent at 24 hours (T/C

= 0.76 +

continued at 48 hours and 72 hours (Table l).
differences were significant.

0.05).

This trend

In all cases the

At 50 µg/ml con A, there was also a

significant reduction in bone resorption, although it was not as
pronounced as it was at 100 pg/ml.
24 hours (T/C • 0.78

The decrease in resorption seen at

+ 0.06) continued at 48 hours (T/C = 0.66 :!:. 0.05)

and 72 hours (T/C • 0.55

:!:

0.05).

Presently studies are being

conducted to determine whether the decrease in resorption at these
concentrations of con A is due to con A induced inhibition of
osteoclastic activity, or whether these high concentrations are merely
cytotoxic to osteoclasts (see Appendix A).
At mitogenic concentrations of con A (2.0 µg/ml), the
concentration that results in peak proliferation of rat lymphocytes in
vitro (Schneider, unpublished), the 45 Ca released from treated
calvaria did not differ significantly from that of control calvaria at
24, 48 and 72 hours.

However, at a concentration of 0.1 µg/ml con A

there was an increase in bone resorption.
seen as a trend at 24 hours (T/C • 1.32
48 hours (T/C • 1.44 + 0.21).

:!:

This increase, which was
0.24), became significant at

Although there was a slight decrease in

the mean T/C ratio at 72 hours (T/C • 1.36 :!: 0.19), the increase in
resorption remained significant (Table 1).

Studies must be conducted

to determine whether the increase in bone resorption seen at low
concentrations of con A is the result of a direct or an indirect
stimulatory effect of con A on the osteoclast.
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DISCUSSION

Numerous investigators have recently probed the osteoclast
membrane attempting to demonstrate receptor sites for various hormones
and biologically active molecules which regulate osteoclastic
activity.

In an in vitro study utilizing

125

I-calcitonin,

localization of calcitonin receptors on the osteoclast membrane has
been demonstrated (Warshawsky, et al., 1980).

Calcitonin receptors

have also been demonstrated on osteoclasts by immunohistochemical
staining (Rao et al., 1981).

However, light microscope

autoradiographs of chick embryo calvaria after exposure to
125 I-parathyroid hormone (PTH; 1-34), another primary hormone
affecting bone resorption, have revealed PTH receptors on osteoblasts,
but not osteoclasts (Silve et al., 1982).

•

The lack of PTH receptors

on osteoclasts is also supported by the recent findings of Chambers
and Dunn (1982); the addition of PTH to cultures of isolated
osteoclasts caused no change in their behavior or morphology.
The hypothesis is that mononuclear phagocytes are the precursors
of osteoclasts has created an intense investigation to determine if
these two distinct cell types share a common lineage.

Several studies

have focused on membrane characteristics to determine whether or not
certain receptor sites known to exist on macrophages, can also be
demonstrated on osteoclasts.

The findings of one study which

supported this hypothesis, indicated that elicited peritoneal
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mononuclear phagocytes possess functional receptors for both PTH and
CT (Minkin et al., 1977).

Although Fe and C3 receptors are present on

macrophages, no one has been able to demonstrate these receptors on
osteoclasts either in situ (Shapiro et al., 1979; Hogg et al., 1980)
or in vitro (Chambers, 1979).
Lectins, proteins that selectively bind carbohydrates but do not
have enzymatic activity, were initially used to study the surface
structure and function of lymphocytes.

The addition of certain

lectins to cultured lymphocytes results in changes in their surface
morphology and function, e.g. lectins have mitogenic activity.
Recently, lectins have also been used to study the cell membrane
structure and function of a variety of other specific cell types,
including phagocytic cells.

Haimovitz et al. (1982) demonstrated that

the in vitro maturation of monocytes to macrophages was accompanied by
a decrease in the ability to bind fluorescein-labeled peanut
agglutinin.

Horton et al. (1982) demonstrated a dose-dependent

decrease in resorption of

45

Ca pre-labeled long bones incubated in

high concentrations of con A (50 µg/ml and 100 pg/ml).

Subsequently

TEM studies of osteoclasts incubated in 50 µg/ml con A, revealed
specific ultrastructural changes associated with inhibition of
osteoclastic activity (Ryder et al., 1982).

These results suggested

the possibility of specific con A binding sites on osteoclasts.
Barnicot (1947) reported the peripheral distribution of
osteoclasts on the inner surface of the flat bones of the skull of
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io-day old mice.

This endocranial surface of calvaria represented an

easily accessible

sit~

to study membrane receptors on osteoclasts.

SEM has been successfully used to identify resident bone cells on the
endocranial surface of isolated calvaria (Jones and Boyde, 1976; Jones
and Boyde, 1977).

Therefore, in this study calvaria were scanned for

osteoclasts immediately adjacent to the sagittal and frontoparietal
sutures.

Fields of osteoblasts occupied centrally located regions of

the flat skull bones.

The existence of con A binding sites on

osteoclasts and osteoblasts was revealed using the methods described
by Schneider et al (1979) and Brown and Revel (1976).
The

45

Ca bone release assays were conducted to evaluate the

effects of various concentrations of con A on the bone resorbing
capacity of osteoclasts.

The increased release of

45

Ca from the

calvarial halves incubated in 0.1 pg/ml con A at each of the three 24
hour time periods, may be the result of a direct con A-mediated
stimulation of osteoclastic activity, or it may be mediated
indirectly, following interaction of con A with another cell type.
Con A, by virtue of its binding to specific sugar residues, may
directly alter the functional state of the osteoclast resulting in
increased bone resorption at low concentrations.

Alternatively, con A

may act indirectly through an intermediary cell.

The mechanism by

which lectins stimulate lymphocyte production of osteoclast activating
factor (OAF) has been well documented (Horton et al., 1972; Horton et
al., 1974).

The release of OAF by lymphocytes stimulates osteoclastic
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activity resulting in an increased resorption of bone.
The activity of osteoclasts incubated in a mitogenic
concentration of con A did not significantly differ from that of
osteoclasts incubated in control media.

This result argues against

the possible role that OAF may play in the indirect stimulation of
bone resorption.

The significant reduction in bone resorption

observed at 50 and 100 µg/ml con A, is probably the result of a
dose-dependent con A-mediated inhibition of osteoclastic activity as
indicated by the TEM studies of osteoclasts incubated in 50 µg/ml for
48 hours (Ryder et al., 1982).

Presently, experiments are in progress

to verify the reversal of this inhibition of osteoclasts by removing
con A from the culture media after 24 hours of incubation (see
Appendix A).
Chambers and Dunn (1982) and Chambers and Magnus (1982) have
described various inhibitory morphological changes observed in
cultured osteoclasts treated with calcitonin and prostacyclin as
visualized by phase contrast microscopy.

Similarly, morphological

characteristics of presumably active and inhibited osteoclasts, as
visualized by SEM, have been described, both in situ (Jones and Boyde,
1977) and in vitro (Allen et al., 1981).

If indeed the decrease in

the bone resorbing activity of osteoclasts observed at high
concentrations of con A is due to con A-mediated inhibition, and the
stimulation of osteoclasts at low concentrations is a direct effect of
con A, this culture system will be useful in describing specific
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morphological characteristics of osteoclasts by SEM.
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Fig. 1.

Osteoclast treated with con A and hemocyanin
demonstrating a rough surface, the result of
hemocyanin uniformly distributed over the dorsal
(unapposed) surface.

Fig. 2.

Bar equals 5.0 um.

High magnification of an osteoclast treated with
con A-hemocyanin.

The hemocyanin molecules appear

as small elevations, giving the microvilli and flat
.) areas of the cell surface a highly irregular outline.
Bar equals 0.5 um.
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Fig. 3.

High magnification of labeled osteoclast illustrating
densely packed hemocyanin molecules on the flat areas
of the plasme membrane.

Fig. 4.

Bar equals 0.5 um.

Hicrovilli at the lateral border of a labeled
osteoclast shows numerous marker molecules.
equals 0.5 um .

.)

Bar
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Fig. 5.

Field of osteoblasts from a sample treated with con A
and hemocyanin.
molecules.

Fig. 6.

The rough surface is due to hemocyanin

Bar equals 5.0 um.

High magnification of a labeled osteoclast, as in figure
5.

Note the presence of uniformly distributed

hemocyanin molecules.

Bar equals 0.25 um.
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Fig. 7.

Control osteoclast treated with con A,
mannoside, and hemocyanin.
cell surface.

Fig. 8.

No label is present on the

Bar equals 5.0 um.

High magnification of a control osteoclast, as in figure
7.

The smooth outline of microvillous projections is

apparent.

'

~-methyl

Bar equals 0.5 um.
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Fig. 9.

A field of osteoblasts from a control sample, treated
with con A, ..C:-methyl mannoside, and hemocyanin.
equals 5.0 um.

Fig. 10. High magnification of the surface of a control
osteoblast.

'

Bar equals 0.25 um.

Bar
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45ca Bone Release Assay

Table 1

Concentration of
con A

24 hour
T/C Ratioa

pb

48 hour
T/C Ratio

p

<O. 1

1.44 ± .21

<.05

72 hour
T/C Ratio

p

0.1 µg/ml

1.32 ± .24

2.0 µg/ml

1. 07 ± • 12 N• S.

1.05 ± .10 N.S.

1.03 ± .11

50 µg/ml

0.78 ± .06 <.01

0.66 ± .05

<.005

0.55 ± .05 <.002

0.76 ± .05 <.005

0.55 ± .01

< .001

0.42 ± .04 <.001

100 µg/ml

1.36 ± .19 <.05

a T/C ratio: Mean treated to control ratio of three pairs of corresponding
calvar1al halves and the standard deviation.
b p • probability that the mean T/C ratio was the same as the mean
as detennined by a two-tailed student t-test.
c N.S. = not significant

CIC ratio

N.S.

CHAPTER IV
LECTIN-MEDIATED EFFECTS ON BONE
RESORPTION IN VITRO
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ABSTRACT

Lectins are proteins that are highly specific in their saccharide
binding requirements.

Although lectins have been used extensively as

--

in vitro biological probes to study the structure and function of

cells and tissues, few studies have used lectins to evaluate the
skeletal system.

Organ cultures of

45

ca pre-labeled bone have been

used as in vitro models to assess the functional effects of various
exogenous and endogenous mediators of osteoclastic bone resorbing
activity.

In a previous study, we demonstrated that concanavalin A

(con A) has a dose-dependent biphasic effect on the bone resorbing
capacity of osteoclasts using a

45

Ca bone-organ culture system; bone

resorption was stimulated at low concentrations and inhibited at high
concentrations.

In this study we compared the effects of the

following 4 lectins, con A, wheat germ agglutinin {WGA), soybean
agglutinin {SBA) and peanut agglutinin {PNA), each with distinctly
different saccharide binding specificities, on bone resorption.
cultures of

45

Organ

Ca pre-labeled calvariae were established to quantitate

bone resorption and each lectin was tested at a concentration of SO
pg/ml.

Both con A and WGA inhibit bone resorption, although the

VGA-mediated effect is not as pronounced as that of con A.

In

contrast, neither SBA nor PNA have any effect on bone resorption in
comparison to the control assay.

These observations indicate that

con A- and WGA-mediated inhibition of bone resorption is not a
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generalized phenomenon that occurs subsequent to the binding of any
lectin at the same concentration, suggesting that the specificity of
lectin binding to cell surface receptors is an important factor in the
regulation of cellular function.

Furthermore, lectins such as con A

and WGA can be used as in vitro models to study the morphological and
biochemical events associated with changes in osteoclastic activity.
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INTRODUCTION

Lectins are proteins that exhibit a variety of biological
effects, some of which mimic the effects of endogenous, physiological
agents that regulate cellular function in vivo.

Therefore, lectins

have been used as in vitro models to study the biochemical events and
morphological changes associated with alterations of cellular
activity.
probes.

Lectins offer a number of attractive features as biological
They are highly specific in their cell surface saccharide

binding requirements.

Hapten inhibition studies have demonstrated

that the interactions between lectins and cell surface saccharides can
be inhibited by the addition of simple sugars.

Most of the lectins

that have been isolated and analyzed to date are composed of multiple
subunits which are held together by non-covalent bonds.

These

subunits are polypeptide chains that frequently contain covalently
bound carbohydrate side chains.

There are a multitude of lectins that

are commercially available in high purity and they can be conjugated
to a variety of ultrastructural and cytochemical marker molecules.
Concanavalin A (con A) is the most widely used lectin in
biological assays and many of its properties have been well-documented
and thoroughly investigated.

Other lectins that are frequently used

to study the structure and function of cells and tissues include wheat
germ agglutinin (WGA), soybean agglutinin (SBA) and peanut agglutinin
(PNA).

The sugar specificities of con A, WGA, SBA and PNA are
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distinctly different from one another (Table 1).

All of the sugar

residues to which these lectins bind are common to mammalian
membrane-associated glycoconjugates.
The biological effects of these 4 lectins have been investigated
in a variety of cellular systems both in vivo and in vitro.

However,

few studies have used lectins to evaluate the structure and function
of the skeletal system.

Wang et al. (1982) demonstrated that the in

vivo administration of PHA-P caused a significant increase in the
number and size of long bone osteoclasts.

Horton et al. (1982)

demonstrated a decrease in resorption of long bones cultured in the
presence of high concentrations of con A (50 and 100 µg/ml).
Subsequent transmission electron microscopy of these con A-treated
osteoclasts revealed ultrastructural changes associated with
inhibition of osteoclastic activity (Ryder et al., 1982).
The studies involving the skeletal system indicate that some
lectins can induce changes in the structure and function of bone
cells, particularly osteoclasts.

The osteoclast is a large

multinucleate cell that is widely accepted as the primary effector
cell responsible for normal bone resorption (Marks, 1983).
previous study, we conducted a series of in vitro

45

In a

Ca bone release

assays to evaluate the effect of various concentrations of con A on
the bone resorbing capacity of osteoclasts (Popoff and Schneider,
1983).

The bone mineral release assays demonstrated that con A has a

biphasic effect; at a low concentration (0.1 µg/ml) con A increased
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bone resorption, whereas at higher concentrations (50 and lOOpg/ml)
con A inhibited bone resorption.

In this study we were interested in

comparing the effects of the lectins con A, WGA, SBA and PNA, each
with different saccharide binding specificities, on bone resorption.
We used a bone-organ culture of

45

Ca pre-labeled calvariae to

quantitate bone resorption and tested each lectin at a concentration
of 50 µg/ml.
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MATERIALS AND METHODS

The procedure employed in these bone mineral release assays is
similar to that described in a previous study (Popoff and Schneider,
1983).

The calvariae of 7-day old Norway Hooded rats were pre-labeled

by injecting the animals with 40 µCi of

45

Ca per rat (specific

activity 10-40 mCi/mg calcium, Amersham, Arlington Heights, 11.).
Three days later, the animals were anesthetized with ether and
sacrificed.

The calvariae were removed under sterile conditions and

placed into Hanks' Balanced Salt Solution (HBSS).

The dura mater and

periosteum were dissected off the endocranial surface and the
calvariae were rinsed in HBSS.

Each calvaria was split longitudinally

down the sagittal suture, and corresponding halves were placed into
adjacent wells of a 24-well Costar tissue culture cluster.

Each well

contained 2 ml of BGJb medium supplemented with 5% Fetal Bovine Serum,
100 units/ml Penicillin-Streptomycin and 0.292 mg/ml Glutamine.
calvarial halves were incubated at 37°C for 24 hours in 5% co
to remove the labile

45

ca.

2

The
and air

After 24 hours, the medium was discarded

and the wells were rinsed with HBSS to remove any residual

45

ca.

At this point, the calvarial samples were divided into 5 groups
with each group containing 6 matching calvarial halves.

The 5 groups

correspond to the 4 lectins, con A, WGA, SBA, and PNA, to be tested
and one group for the control release assay.

In the experimental

cultures, one half of each particular calvaria was incubated in 2 ml
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of supplemented BGJb medium containing one of the four lectins at a
concentration of 50 µg/ml, while the other half was incubated in 2 ml
of supplemented BGJb medium without the addition of any lectin and
used as an internal control.

In the control cultures both halves of

each pair were incubated in supplem:nted BGJb medium in the absence of
lectin.

At 24, 48 and 72 hours, 0.2 ml samples of culture medium were

pipetted off each well and added to 10 ml Biocount liquid
scintillation counting cocktail (Research Products International,
Mount Prospect, Il.).

Duplicate samples were taken from each well and

the remaining medium was discarded at 24 and 48 hours.

Each well was

rinsed with HBSS and replenished with 2 ml of fresh medium.

The

cultures were terminated at 72 hours and the remaining bone samples
were placed into scintillation vials and digested in 0.5 ml formic
acid at l00°c for 30 minutes.

Following the bone digest, 10 ml

counting cocktail was added to each vial.

All samples were counted in

a Beckman LS 7000 Liquid Scintillation System.
performed so that the percent of
sample with respect to the total
could be calculated.

45
45

The bone digest was

Ca released from each calvarial
Ca initially present in that sample
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RESULTS

The

45

Ca bone release assays were conducted to evaluate the

effects of the lectins, con A, WGA, SBA and PNA, on bone resorption.
Bone resorption was quantitated by the amount of

45

ca released into

the tissue culture medium during three 24 hour time periods after the
release of labile

45

Ca.

Values for the level of radioactivity (cpm)

were obtained by counting duplicate samples from each well at each
time period.

The counts per minute obtained from duplicate samples

never differed by more than 3%.

The percent

45

ca released from each

calvarial sample (% release) at each sampling time point was
calculated from the cpm values after the bone digest was performed.
The value (% release) for each calvarial half incubated in the
presence of a specific lectin was divided by the value (% release) of
the corresponding half incubated in control medium (no lectin added)
to give a treated/control (T/C) ratio for each calvaria.

The mean T/C

ratio for each of the four experimental groups was calculated and
compared to the mean control/control (C/C) ratio obtained from the
control assay to determine whether the observed changes in bone
resorption were significantly different.

Significance was evaluated

by a two-tailed Student t-test for the difference between two means.
The mean C/C ratios obtained from paired calvarial halves
incubated in the absence of lectin varied slightly from the expected
Value of 1.00 (24 hr. T/C

= 1.02 ± 0.02;

48 hr. T/C

= 1.04 ± 0.02;

72

67
hr· T/C

=

1.02

.±

0.03).

The calvarial samples incubated in the

presence of con A showed a significant decrease in bone resorption at
24 (T/C

= 0.78 -+

0.06), 48 (T/C

o.06) hours (Fig. 1).

= 0.66 -+

0.05), and 72 (T/C

= 0.55 +

In a previous study (Popoff and Schneider,

1983), we have shown that the reduction in mineral mobilization
mediated by con A at a concentration of 50 µg/ml is reversible,
indicating that this concentration is inhibitory rather than cytotoxic
to the bone resorbing osteoclasts.

In the samples incubated in

50 µg/ml WGA, there was a slight decrease in bone resorption at 24
hours (T/C • 0.95

::!:

0.03), which became significant at 48 (T/C • 0.84

+ 0.04) and 72 (T/C • 0.71

.±

0.05) hours (Fig. 1).

The decrease

observed in the WGA-treated samples was not as pronounced as that
observed in the con A-treated samples at each of the sampling time
points.

On the contrary, the

45

Ca released from the calvarial halves

incubated in the presence of either SBA or PNA did not differ
significantly from that of control halves at any sampling time point
(Fig. 1).

The T/C ratios obtained from the SBA-treated assay were

1.00 + 0.04 at 24 hours, 0.98
hours.

± 0.08
hours.

± 0.05

at 48 hours and 0.98 + 0.05 at 72

The T/C ratios obtained from the PNA-treated samples were 1.01
at 24 hours, 0.97 + 0.01 at 48 hours and 0.94 + 0.06 at 72
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DISCUSSION

The lectins con A, WGA, SBA and PNA are highly specific in their
cell surface saccharide binding requirements and the
membrane-associated saccharides to which they bind are distinctly
different from one another (Table 1).

Con A has a broad biological

applicability primarily because it recognizes 2 commonly occurring
cell surface saccharides,

~-D-mannose

and o(-D-glucose.

Although it

was originally postulated that the specificity of con A is directed
toward a single sugar residue, studies by So et al. (1968)
demonstrated that the con A binding site is more complex in both its
primary structure and three-dimensional configuration than originally
proposed.

WGA binds to oligosaccharides containing terminal

N-acetylglucosamine (GluNAc) residues, with preferential binding to
dimers and trimers of this saccharide.

SBA preferentially binds to

oligosaccharides containing of..- or p-linked N-acetylgalactosamine
(GalNAc) residues, and to a lesser extent to D-galactose residues.
PNA binding is directed toward D-galactose residues, although this
lectin binds to the disaccharide, galactosyl {1-l,3GalNAc (T-antigen),
with greatest affinity.

Con A, WGA, SBA and PNA are multimeric

lectins; con A and PNA are each composed of 4 identical subunits,
whereas WGA and SBA are each composed of 2 identical subunits (Table
1).

SBA and PNA are glycoproteins and the sugars which have been

isolated from these lectins are common to animal cell membranes.

In
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contrast, con A and WGA are devoid of covalently bound carbohydrate
side chains (Table 1).
In this study, a series of

45

Ca bone release assays were

conducted using a lectin concentration of 50 pg/ml for each of the 4
lectins to be tested.
inhibit the release of

The results demonstrate that both con A and WGA
45

Ca in cultures of pre-labeled calvarial

explants, although the WGA-mediated effect is not as pronounced as
that of con A.

On the contrary, neither SBA nor PNA have any effect

on bone resorption in comparison to the control assay run in the
absence of any lectin.

These findings indicate that the inhibition of

bone resorption mediated by con A, and to a lesser extent by WGA, at a
concentration of 50 pg/ml is not a generalized phenomenon that occurs
subsequent to the binding of any lectin at this concentration.

This

conclusion would suggest that the specificity of lectin binding to
cell surface receptors is an important factor in the regulation of
cellular function that is mediated by a particular lectin.

Studies

should be conducted to evaluate possible mechanisms that could be
responsible for the differential effects of these lectins on bone
resorption.
Because of the difficulty in obtaining pure populations of
osteoclasts, most of the studies on bone resorption are performed on
intact animals or bone-organ cultures.

These systems do not permit

detailed analysis of the cellular mechanisms of bone resorption
(Teitelbaum et al., 1979).

Studies by Mundy et al. (1977), Kahn et
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al. (1978) and Teitelbaum et al. (1979) have demonstrated that
monocytes and macrophages are capable of resorbing devitalized bone in
vitro.

------

The studies by Kahn et al. (1978) and Teitelbaum et al. (1979)

also demonstrated that optimal macrophage-mediated mineral
mobilization requires cell-matrix contact.

Since macrophages are

capable of attaching to and subsequently degrading a bone matrix, the
macrophage-devitalized bone culture system serves as a useful model to
study the mechanisms of bone resorption in tissue culture (Bar-Shavit
et al., 1983a).

Recent studies by Bar-Shavit et al. (1983b,c) have

shown that the attachment of macrophages to bone is a regulated
process that is mediated, in part, by certain saccharides located on
the cell and/or bone surfaces.

These findings indicate that the

attachment of resorbing macrophages to the bone matrix is an important
component of the process of bone resorption and that the
oligosaccharide-mediated binding mechanism that links the resorbing
macrophages to bone is essential for normal resorptive activity.

The

macrophage-devitalized bone culture system could be used to evaluate
the effects of lectins, that have differential effects on

45

Ca release

in cultures of pre-labeled calvariae, on the morphological and
functional aspects of the macrophage-bone interaction.

71

LITERATURE CITED
Bar-Shavit, Z., Teitelbaum, S.L., Reitsma, P., Hall, A., Pegg, L.E.,
Trial, J., Kahn, A.J. (1983) Induction of monocytic differentiation
and bone resorption by 1,25-dihydroxyvitamin D . Proc. Nat. Acad.
3
sci., 80, 5907-5911.
Bar-Shavit, Z., Teitelbaum, S.L., Kahn, A.J. (1983) The attachment of
bone-resorbing mononuclear cells to bone surfaces is mediated by
glycoproteins. J. Dent. Res.,~' 680A.
Bar-Shavit, z., Teitelbaum, S.L., Kahn, A.J. (1983) Saccharides
mediate the attachment of rat macrophages to bone in vitro. J. Clin.
Invest., '!l:_, 516-525.
Horton, J.E., Ryder, M.I., Jenkins, S.D. (1982) Effects by lectins on
osteoclastic bone resorption in vitro. J. Dent. Res., 2..!_, 337A.
Kahn, A.J., Stewart, C.C., Teitelbaum, S.L. (1978) Contact-mediated
bone resorption by human monocytes in vitro. Science, 199, 988-990.
Marks, S.C. (1983) The origin of osteoclasts: The evidence, clinical
implications and investigative challenges of an extraskeletal source.
J. Oral Pa th., _g, 226-256.
Mundy, G.R., Altman, A.J., Gondek, M.D., Bandelin, J.G. (1977) Direct
resorption of bone by human monocytes. Science, 196, 1109-1111.
Popoff, S.N., Schneider, G.B. (1983) Ultrastructural localization of
concanavalin-A binding sites on bone cells: Effects of con A on
osteoclastic bone resorption. Scanning Electron Microsc. 1983 II,
959-967.
Ryder, M.I., Jenkins, S.D., Horton, J.E. (1982) Novel morphological
expression of concanavalin A (con A)-treated osteoclasts. J. Dent.
Res., 2..!_, 315A.
So, L.L., Goldstein, I.J. (1968) Protein-carbohydrate interaction.
XIII. The interaction of concanavalin A with -<-mannans from a variety
of microorganisms. J. Biol. Chem., 243, 2003-2007.
Teitelbaum, S.L., Stewart, C.C., Kahn, A.J. (1979) Rodent peritoneal
macrophages as bone resorbing cells. Cale. Tiss. Intl., :!2._, 255-261.
Wang, T.M., Jee, W.S.S., Woodbury, L.A., Matthews, J.L. (1982) Effects
of phytohemagglutinin-P (PHA-P) on bone of the growing rat. Metab.
Bone Dis. Rel. Res.,!!._, 193-199.

72

Fig. 1.

45

Ca bone release assay.

SBA and PNA had no significant

effect on bone resorption at a concentration of 50
pg/ml, whereas con A and WGA inhibited bone resorption
at this concentration .
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Table 1

Lectin
Concanavalin A
(Con A)

Lect1n Spec1f1c1ty

Source
Canavalia ensifonnis
(Jack bean) seeds

Saccharide Specificity
and
Binding Affinity
a-0-mannose
a-D-glucose

Structure
Cation
Requirement
+

Chemica 1
Composition

# of
Subunits

MW (daltons)

protein

tetramer

104 ,000

---------------------- ----------------------- ------------------------ -------------- -------------- -------------- -------------Peanut Agglutinin
(PNA)

Arachis hypogaea
(peanuts)

D-galactose
galactosyl 6-1,3 GalNAc

-+

gl ycoprotei n

tetramer

110,000

---------------------- ----------------------- ------------------------ -------------- -------------- 1-------------- --------------Soybean Agglutinin
(SBA)

Glycine max (soybean)
seeds

D-GalNAc
D-galactose

+

glycoprotein

tetramer

120,000

---------------------- ----------------------- ------------------------ -------------- -------------- 1-------------- --------------Wheat Germ Agglutinin Triticum vulgaris
(WGA)
(wheat germ)

(D-GluNAc) 3/Z/l

-

protein

dimer

36,000

CHAPTER V
THE EFFECTS OF LECTINS ON THE INTERACTION
BETWEEN MACROPHAGES AND BONE IN VITRO:
A MORPHOLOGICAL AND FUNCTIONAL STUDY
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SUMMARY

Recent studies have demonstrated that the attachment of elicited
rat macrophages to bone is mediated by specific saccharides located on
the cell and/or bone surfaces.

We have used a macrophage-bone culture

system to study the effects of 2 lectins, concanavalin A (con A) and
soybean agglutinin (SBA), on the morphology of macrophage attachment
to a devitalized bone surface and subsequent functional activity.
Macrophages were obtained from 3-4 week old rats by peritoneal lavage
and the adherent pool was used to prepare cell suspensions.

Con A-

treated, SBA-treated or control cell suspensions were aliquoted onto
the endocranial surface of devitalized rat calvariae.

The cells were

allowed to attach for lh at 37°c, after which, the bone samples were
removed from culture and prepared for scanning electon microscopy
(SEM).

The morphology of con A-treated macrophages attached to bone

was markedly different from that of control or SBA-treated cells.
Con A altered the attachment and subsequent spreading of macrophages
on bone as visualized by SEM.

Furthermore, the number of con A-

treated cells that attached to bone and the average surface area of
cell membrane apposed to the matrix was significantly different from
that of control or SBA-treated cells.

A 45 Ca bone release assay was

performed to evaluate the functional significance of the morphological
findings.

Lectin-treated or control cell suspensions were allowed to

attach to the endocranial surface of 45 ca pre-labeled calvariae for
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lh·

Following attaclunent, the samples were cultured for 72h.

The

con A-treated cultures demonstrated a significant decrease in the
release of 45 Ca after 48 and 72h in comparison to control
while the

45

c~ltures,

Ca released from SBA-treated cultures did not differ

significantly from controls.

These results suggest that certain sugar

residues common to membrane-associated glycoconjugates and the organic
component of the bone matrix regulate the attachment of macrophages to
bone and their subsequent bone resorbing activity.
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INTRODUCTION

The hypothesis that the osteoclast precursor is extraskeletal in
origin has been recently accepted (Marks 1983).

Although the

definitive origin of the osteoclast remains uncertain, there is
abundant evidence to support the hypothesis that osteoclasts are
derived from mononuclear cells of hemopoietic origin, possibly of the
monocytic lineage (Walker 1975; Marks and Walker 1981; Schneider and
Byrnes 1983).

In addition to the investigative effort to establish a

common lineage between the osteoclast and the macrophage mononuclear
cell, it has been well-documented that cells of the mononuclear
phagocyte system are capable of resorbing devitalized bone in vitro
(Mundy et al. 1977; Kahn et al. 1978; Teitelbaum et al. 1979).

The

studies by Kahn et al. (1978) and Teitelbaum et al. (1979) also
demonstrated that optimal macrophage-mediated mineral mobilization
requires cell-matrix contact.

These findings indicate that the

attachment of resorbing mononuclear cells to the bone matrix is an
important component of this process.
More recently, Bar-Shavit et al. (1983a,b) have shown that the
attachment of macrophages to bone is a regulated process that is
mediated, in part, by saccharides located on the cell and/or bone
surfaces.

These investigators have also shown that glucocorticoids

enhance the attachment of macrophages to bone in a dose-dependent
manner which parallels the dose-dependent stimulation of
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macrophage-mediated bone resorption by glucocorticoids (Bar-Shavit et
al. 1984).

The increase in macrophage attachment involves

glucocorticoid-induced alterations of cell surface oligosaccharides.
Bar-Shavit et al. (1982, 1983c) also demonstrated that macrophages
attach to osteomalacic bone with significantly less avidity than
normal matrix.

They attributed this reduction in binding to the

absence or inaccesibility of the appropriate bone matrix
oligosaccharides.

From these studies it was concluded that the

oligosaccharide-mediated binding mechanism which links the resorbing
mononuclear cells to bone is essential for normal resorptive activity.
Since monocytes and macrophages are capable of attaching to and
subsequently degrading a mineralized bone matrix, the macrophage-bone
culture system serves as a useful model to study the interaction
between macrophage mononuclear cells and bone.

Therefore, we used a

macrophage-bone culture system to study the effects of two lectins,
concanavalin A (con A) and soybean agglutinin (SBA), on the morphology
of cell attachment and subsequent functional activity.

Lectins are

proteins that are highly specific in their saccharide binding
requirements.

Lectins have been used extensively in biological

assays, particularly as probes to study the strucure and activity of
membrane components.

The two lectins employed in this study have

saccharide binding specificities that are distinctly different from
one another.

Con A binds to oligosacharides witho(.-linked D-glucose

and D-mannose residues, whereas SBA preferentially binds to
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oligosaccharides with ol- or ~-linked N-acetylgalactosamine (GalNAc)
residues, and to a lesser extent to D-galactose residues.

For this

study, scanning electron microscopy (SEM) was used to assess the
qualitative and quantitative differences in the attachment of
macrophages to bone in the presence and absence of lectin.
Furthermore, a

45

Ca bone release assay was performed to evaluate the

functional significance of the morphological findings.
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MATERIALS AND METHODS

Mononuclear cells for all experiments were obtained from 3 to 4
week old Norway Hooded rats by intraperitoneal injection of cold
0

saline (4 C), as described by Schneider and Byrnes (1983).

The

abdomen was massaged for a few minutes and the fluid was aspirated
from the peritoneal cavity.

Adherent cells were separated from

nonadherent cells by incubating the peritoneal washes in RPM! 1640
medium supplemented with 10% Fetal Bovine Serum in 35 mm plastic
tissue culture dishes (5 X 10

6

cells/dish).

After 2h, the nonadherent

pool was decanted and the cultures were rinsed in phosphate buffered
saline (PBS).

The remaining attached cells were incubated in

calcium-, magnesium-free Hanks' Balanced Salt Solution (HBSS) for 15
min at 4°C.

The cells were removed from the plastic surface by gentle

scraping using a rubber policeman.
were counted on a hemocytometer.

The resulting cell suspensions
Approximately 95% of the adherent

cells were macrophages, as assessed by their ability to phagocytose
the particulate dye, neutral red.

Morphology and quantitation of macrophage attachment to bone in the
Rresence of con A and SBA
The cell surface morphology of macrophages attached to bone in
the presence of con A and SBA was visualized by scanning electron
microscopy (SEM).

Three cell suspensions containing equivalent
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numbers of macrophages were prepared for this experiment: 1) a con A
treated cell suspension in BGJb medium containing 50 pg/ml con A
(Pharmacia, Piscataway, N.J.); 2) an SBA treated cell suspension in
BGJb medium containing 50 pg/ml SBA (Pharmacia, Piscataway, N.J.); 3)
and a control suspension of cells in BGJb medium without the addition
of lectin.

The BGJb medium used in all tissue culture procedures was

supplemented with 10% Fetal Bovine Serum, 100 units/ml
Penicillin-Streptomycin and 0.3mg/ml Glutamine.

The lectin

concentration of 50 pg/ml was selected based upon previous results
which demonstrated that con A significantly inhibits the release of
45 ca from a bone organ culture system at this concentration, whereas
the release of 45 Ca from SBA-treated cultures is not significantly
different from controls (Popoff et al. 1984).
Devitalized bone chips were prepared from the calvariae of 10 day
old Norway Hooded rats by freeze-thawing and sonication.

Three

devitalized bone chips were placed onto the bottom of each of 6 tissue
culture wells, the wells being divided into 3 groups corresponding to
the three cell suspensions.

The cell suspensions were then layered

over the bone chips and the cells were allowed to attach for lb.
Bar-Shavit et al. (1983) have shown that elicited rat peritoneal
macrophages bind to bone in a temperature-dependent and saturable
0

manner with maximal attachment occurring at 60 min at 37 C.

Following

attachment the bone chips were removed from culture and rinsed in PBS.
After the bone attachment assay, all bone samples were fixed in
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2.5% glutaraldehyde in 0.1 M cacodylate buffer for lh.

Following

fixation, the samples were rinsed in cacodylate, dehyrated through a
graded series of ethanol, critical point dried via

co 2

using a Denton

DCP-1 (Denton Vacuum, Cherry Hill, N.J.), attached to aluminum stubs
and coated (20 nm thickness) with Gold/Palladium using a Hummer VI
sputter-coating apparatus (Technics, Alexandria, Va.).

The specimens

were scanned using an ISI SX40 (Santa Clara, Ca.) at an accelerating
voltage of 15kV and either a 0

0

or 45

0

tilt.

These samples were used

to evaluate cell surface morphology and to quantitate the attachment
of macrophages to bone.
To quantitate the number of macrophages attached to the bone
surface, 5 different fields of each bone sample were selected using
identical x:y coordinates for each sample.

These fields were

photographed at 300X, a magnification that allows for the accurate
~

identification of individual cells.

The cells were then counted on a

Zeiss Videoplan Image Analyzer (Carl Zeiss, New York, N.Y.).
validate this method of quantitation by SEM, a
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To

Cr bone binding assay

similar to that described by Bar-Shavit et al. (1983d) was employed.
Macrophages were radiolabeled by incubation for lh at 37°c in a
solution containing Na
50 pCi/10 X 10 6 cells.

51

Cr0

4

in RPMI 1640 medium at a concentration of

After washing the radiolabeled cells in PBS,

they were resuspended in the following media; control cells in
supplemented BGJb medium and treated cells in supplemented BGJb medium
containing 50 pg/ml of con A.

The control and treated cell
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suspensions, each containing an equivalent number of radiolabeled
macrophages, were aliquoted onto the endocranial surface of 6
devitalized calvarial chips and the cells were allowed to attach for
0

lh at 37 C.

All calvarial chips used in this experiment were

identical in size.

After rinsing, the bone chips, with their attached

radiolabeled cells, were counted in a Beckman Gamma 4000 system.

A

pre-determined number of radiolabeled cells were also counted,
allowing for an approximate determination of the number of attached
macrophages from the counts per minute (cpm) obtained from the gamma
counter for each bone chip.
To quantitate the average cell surface area apposed to the bone
surface in the presence or absence of either con A or SBA, fields of
attached macrophages were photographed at lOOOX.

From these

micrographs, the perimeter of individual cells on the bone surface
could accurately be traced using a Zeiss Videoplan Image Analyzer
(Carl Zeiss, New York, N.Y.).

100 cells in each group were traced on

the image analyzer, which was calibrated to convert this measurement
2

parameter into the corresponding surface area in pm •

The individual

surface area measurements in each group were averaged and significance
was evaluated by a two-tailed student t-test.

Macrophage mediated release of bone mineral
The calvariae of twelve 7-day old Norway Hooded rats were
pre-labeled by injecting the animals with 40 pCi of

45

Ca per rat.
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Three days later, the calvariae were removed and the dura mater was
dissected off the endocranial surface.

After being devitalized, each

calvaria was split longitudinally down the sagittal suture and
corresponding halves were placed into adjacent tissue culture wells.
The culture plates were placed under an ultraviolet light source for
12h to assure that all calvariae were sterile.

Following

sterilization, 2 ml of PBS was added to each well for 24h to remove
the labile

45

Ca.

After the washout period, lectin-treated and control macrophage
cell suspensions were prepared in supplemented BGJb medium as
previously described.

The calvarial samples were divided into 2

groups (con A and SBA), each containing 6 matching calvarial pairs.
Two ml of either the con A-treated or SBA-treated cell suspension was
aliquoted into the wells containing one half of each calvarial pair,
while 2 ml of the control cell suspension was aliquoted into the wells
containing the corresponding half of each calvarial pair.

An

equivalent number of cells (treated or control) was aliquoted into
each well.

At 24, 48 and 72h, duplicate 0.2 ml samples of culture

medium were pipetted off each well and added to 10 ml Ready-Solv
liquid scintillation counting cocktail (Beckman, Fullerton, Ca.).

The

remaining medium was discarded at 24 and 48 hours and replenished with
2 ml of fresh medium.

Cell viability in control, con A-treated and

SBA-treated cultures after 72h was determined by the trypan blue dye
exclusion method.
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After terminating the cultures at 72h, the calvarial samples were
rinsed in PBS, placed into scintillation vials, and digested in 0.5 ml
formic acid at l00°C for 30 min.

Following calvarial digest, 10 ml

counting cocktail was added to the vials.
8

All samples were counted in

Beckman LS 7000 Liquid Scintillation System.

was performed so that the percent of
with respect to the total
could be calculated.

45

45

The calvarial digest

Ca released from each calvaria

Ca initially present in that calvaria
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RESULTS

!_orphology of macrophage attachment to bone
0

Macrophages that are allowed to attach to a bone surface at 37 C
in the absence of lectin, will interact with the bone surface and
spread beyond the original site of attachment.

After lh in culture,

the macrophages are in various stages of the spreading process; some
cells exhibit a proportionately large membrane surface area that is
apposed to the bone surface, while others are in a more immature phase
of the spreading process (fig. 1).

Many filopodia as well as some

larger lamellipodia are present at the cell periphery (fig. 2).

The

dorsal, unapposed surface exhibits numerous microspikes (fig. 2).
Macrophages that are allowed to attach to bone in the presence of con
A exhibit a cell surface morphology that is markedly different from
that of controls (fig. 3).

Although the con A-treated macrophages do

attach to the bone surface, they are hindered in their ability to
spread on the substrate.

A much smaller proportion of the total

membrane surface area of con A-treated macrophages is apposed to the
bone matrix in comparison with controls.

Membrane specializations at

the cell periphery are present in the form of a few blunt
lamellipodia, while filopodia are absent; the dorsal surface is
ruffled (fig. 4).

In addition, some of the macrophages are present in

aggregates, most likely the result of the cross-linking of cell
membranes by con A.

Macrophages attaching to bone in the presence of
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SBA exhibit an extensive membrane-substrate interaction similar to
controls.

Many of the SBA-treated macrophages have a large membrane

surface area that is apposed to the bone matrix, while others are less
advanced in the spreading process (fig. 5).

The surface morphology of

SBA-treated macrophages includes large peripheral pseudopodia and a
ruffled dorsal surface (fig. 6).

Macrophage agglutination by SBA is

not nearly as pronounced as with con A; most of the cells are present
either singly or in small clusters.

guantitation of macrophage attachment to bone
The number of macrophages attaching to bone in the presence or
absence of either con A or SBA was quantitated via SEM as described in
Methods.

Significance was evaluated by a two-tailed Student t-test

for the difference between two means.

The number of macrophages

attaching in the con A system is significantly greater than the number
of cells attaching in the absence of lectin (fig. 7).

On

the

contrary, the number of attached SBA-treated cells is not
significantly different from that of controls (fig. 7).

51

A

Cr-labeled macrophage-bone binding assay was performed to confirm

the significant increase in the number of con A-treated macrophages
attaching to bone.

The mean level of radioactivity (cpm) obtained

from control samples was 18,025 + 3097, while the mean cpm for
con A-treated samples was 34,285 + 6118 (p < .005).

The level of

radioactivity for a fixed number of 51 Cr-labeled macrophages was also
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obtained (l.6 X 10

6

cells= 267,118 cpm).

From this data, the
2

relative cpm values were converted to the number of cells per 32 mm ,
the surface area of each bone sample (control 108,151
205,709

.±

.±

18,614; con A

36,603).

The surface area of cell-matrix contact in the presence or
absence of either con A or SBA was quantitated per cell by tracing the
perimeter of attached cells on a Zeiss Videoplan Image Analyzer.

The

average cell surface area of con A-treated macrophages apposed to the
bone surface is significantly less than the average cell surface area
of control macrophages (con A 24.8
p<.001).

.±

2

6.5 pm ; control 55.6

.±

2

17.4 pm ;

On the contrary, the average membrane surface area apposed

to bone in the SBA-treated system is not significantly different from
that of controls (SBA 58.4

~

2

20.l µm ).

Macrophage mediated release of bone mineral
The morphological findings confirm the hypothesis that specific
saccharides common to cell surface and/or matrix associated
glycoconjugates are involved in the interaction between macrophages
and bone.

Therefore, lectins specific for these saccharides can both

qualitatively and quantitatively modify the macrophage-bone
interaction.

A

45

Ca bone release assay was performed to determine

whether the observations made by SEM could be correlated to any
functional differences in the ability of lectin-treated macrophages to

'
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f

release

45

Ca in vitro.

The ability of macrophages to degrade a mineralized bone matrix
was determined by the amount of

45

ca released into the culture medium

during three 24h periods after the release of labile

45

Ca.

Values for

the level of radioactivity (cpm) were obtained by counting duplicate
samples from each well at each time period.

The mean value (cpm) for

each calvarial half incubated in either con A or SBA was divided by
the mean value of the corresponding half incubated in control medium
to give a treated/control (T/C) ratio for each calvaria.
ratio for the two experimental groups was calculated.

The mean T/C

These values

were compared to the mean control/control (C/C) ratio to determine
whether the observed changes in bone resorption were significantly
different.

The C/C ratios were obtained from an assay in which both

calvarial halves of each pair were incubated in the absence of either
lectin.

Significance was evaluated by a two-tailed Student t-test for

the difference between two means.
In the macrophage-bone samples incubated in 50 pg/ml con A, the
same concentration that was utilized for the morphological studies,
there was a marked decrease in the release of 45 ca from bone at 48h
(T/C • 0.83 + .07; p < .005) and 72h (T/C • 0.72
(fig. 8).

On the other hand, the

45

.±

.09; p < .002)

Ca released from the

macrophage-bone samples incubated in 50 pg/ml SBA did not differ
significantly from that of controls at 24, 48 and 72h (fig. 8).

In

addition, the actual C/C values never differed by more than 5% from

,
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~
the ideal value of 1.0 at any of the three sampling time points.

The

viability of macrophages incubated in con A, SBA and control medium
-as also determined after 72h using the trypan blue dye exclusion
•ethod.

Cell viability ranged between 757. to 807. in all wells tested.

This excludes the possibility that the reduction in the release of
45ca from con A-treated samples may have been the result of a
selective increase in cell death at 48 and 72h.
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DISCUSSION

The hypothesis that mononuclear phagocytes are the precursors of
osteoclasts has created an intense investigation to determine if these
two distinct cell types share a common lineage and function.

Most

studies have focused on ultrastructural and functional similarities
between cells belonging to the family of mononuclear phagocytes and
osteoclasts on a bone matrix.

It has been well-documented that cells

of the mononuclear phagocyte system resorb devitalized bone in vitro
(Mundy et al. 1977; Kahn et al. 1978; Teitelbaum et al. 1979).
Glowacki et al. (1981) recently developed a model system in which they
implanted devitalized bone fragments into calvarial defects in rats,
thereby initiating a rapid cell-mediated resorptive sequence.

A

histological and ultrastructural study of these implants by Holtrop et
al. (1982) demonstrated that the cells surrounding the bone fragments
belong to the mononuclear phagocyte system.

However, none of these

cells, even the multinucleate giant cells, had ruffled borders, a
morphological hallmark of osteoclasts, and therefore, could not be
classified as osteoclasts.

Other studies have also demonstrated that

macrophages attached to bone acquire a number of the morphological
characteristics of osteoclasts in culture, with the exception of
ruffled borders (Kahn et al. 1978; Rifkin et al. 1979).

All of these

studies indicate that cells of the mononuclear phagocyte system are
capable of resorbing bone both

in~

and in vitro.
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Hore recently, Bar-Shavit et al. (1983a,b) have used a
macrophage-bone binding assay to show that the attachment of
macrophages to bone can be inhibited by certain sugars, while others
have little or no effect.

In a separate study, they have demonstrated

that the glucocorticoids, dexamethasone and cortisol, enhance the
attachment of macrophages to bone in a dose-dependent manner by
causing alterations of cell surface oligosaccharides (Bar-Shavit et
al. 1984).

On

the other hand, these investigators have shown that

macrophage-bone attachment is greatly reduced in both vitamin D
deficiency and hypophosphatemia (Bar-Shavit et al. 1982; Bar-Shavit et
al. 1983c).

They attribute this reduction in binding to the absence

or inaccessibility of the bone matrix and/or cell surface
oligosaccharides that are essential to the attachment process.

These

studies suggest that the reduction in bone resorption accompanying
certain disease states or the stimulation of resorption induced by
glucocorticoid treatment may, at least in part, depend on the ability
of osteoclasts and their precursors to properly attach to the bone
matrix, a step that appears to be essential for normal resorptive
activity and osteoclast differentiation.
Lectins, proteins that selectively bind carbohydrates but do not
have enzymatic activity, were initially used to study the surface
structure and function of lymphocytes.

More recently, the biological

effects of different lectins on a variety of cellular systems have
been investigated both in vivo and in vitro.

Based on hapten
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inhibition studies, which demonstrate that lectin-ligand binding can
be inhibited by simple

~ugars,

most lectins are highly specific in

their cell surface saccharide binding requirements.

In this study we

used 2 lectins, each having distinctly different saccharide binding
specificities, to study the importance of specific oligosaccharides on
the attachment of macrophages to bone, and the subsequent release of
45ca from the matrix.

Con A binds to o<-linked D-glucose and D-mannose

residues, whereas SBA preferentially binds to-<- or /3-linked GalNAc
residues, and, with lesser avidity, to D-galactose residues.
Therefore, cell surface and matrix associated oligosaccharides
containing these particular sugars will bind the appropriate lectin,
and, as a consequence, the lectin bound oligosaccharides will be
unable to directly participate in the macrophage-bone interaction.
The morphological findings indicate that con A does hinder the
ability of macrophages to interact with the bone matrix.

The membrane

surface area that is apposed to the bone surface in the con A-treated
system is far less than that of control macrophages; the con A-treated
cells exhibit a minimal degree of attachment to the substrate.

On

the

contrary, SBA does not appear to change the attachment and subsequent
spreading of macrophages on bone.

However, the dorsal, unapposed

surface of both con A- and SBA-treated macrophages is ruffled; the
microspikes present on control cells are absent. In addition, the
morphology of the cell periphery is also different in lectin-treated
cells.

These differences in cell surface morphology may be due to the
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processing of membrane-bound lectin complexes.

Many of the biological

effects of lectins are subsequent to binding, which in turn, alters
the structure and activity of membrane components.

Con A has been

used extensively to study the redistribution and endocytosis of
lectin-binding site complexes in a variety of cell types.

An

ultrastructural study by Welsch and Schumacher (1983) demonstrated
that rat pulmonary macrophages bound and incorporated large amounts of
con A in vivo.

Additional studies should be conducted, to assess the

manner in which membrane-bound con A and SBA are processed by these
resident peritoneal macrophages in vitro, including the possible
redistribution and/or endocytosis of these complexes.
The quantitative data demonstrates that approximately twice the
number of con A-treated macrophages attached to the bone surface in
comparison with the number of untreated cells.

Although these results

seem to conflict with the 45 Ca release data, this quantitative
difference is most likely the result of the extensive aggregation of
macrophages by con A.

The cross-linking of cell membranes by con A

may significantly increase the number of cells that appear to attach
to the bone matrix, since those cells that would not attach under
normal conditions appear to be attached to the bone surface by
cross-linking to the cells that are capable of attachment.

The

quantitation of membrane surface area apposed to the bone surface,
demonstrates that the average cell surface area of con A-treated
macrpophages that are in direct contact with the bone matrix is

r
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significantly less than that of control or SBA-treated cells.

The

surface area values presented in the results were measured from SEM
•icrographs, and therefore, are less than the actual surface areas of
cell-matrix apposition in the unfixed state.

Schneider (1976)

demonstrated that during routine SEM tissue processing, cell
shrinkage, due primarily to critical point drying, results in a
greater than 50% reduction in the total cell surface area.
In addition to the morphological observations, the

45

Ca bone

release assay was performed to evaluate the functional effects of
con A and SBA on the macrophage-bone system.

Previous studies on

macrophage-mediated 45 ca release from pre-labeled bone in vitro, have
shown that optimal mobilization of the radioactive label requires
cell-matrix contact (Kahn et al. 1978; Teitelbaum et al. 1979).
Morphological studies have also demonstrated localized areas of matrix
removal immediately underlying bone-resorbing mononuclear cells both
in vivo (Holtrop et al. 1982) and in vitro (Kahn et al. 1978).

Based

on these studies and our own findings, we conclude that the decreased
surface area of cell-matrix contact in the con A cultures may, at
least in part, account for the reduction in macrophage-mediated
mineral mobilization from these cultures.
There also exists an important correlation between the effects of
these 2 lectins on bone mineral mobilization by macrophages and their
effects on 45 ca release in our bone organ culture system.

In previous

studies, we have shown that con A, at a concentration of 50 pg/ml,
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will significantly reduce the release of

45

Ca from a pre-labeled

bone-organ culture system, while SBA, at this same concentration, has
00

functional effect on mineral mobilization (Popoff and Schneider

1983; Popoff et al. 1984).

The results obtained from this study

demonstrate that con A, but not SBA, alters the morphology and
function of macrophages on a bone surface.

These findings suggest

that cell surface and bone matrix oligosaccharides with 9'-D-glucosidic
and c:X-D-mannosidic residues are more likely to be involved in the
macrophage-bone interaction, than oligosaccharides with GalNAc or
D-galactose residues.

However, the possibility that membrane-bound

con A may cause changes in cell activity and processes that play an
important role in mineral mobilization must be assessed.

Although

there is substantial evidence that specific saccharides mediate the
attachment of macrophages to bone, it is not yet clear how much this
affects the function of these cells on a mineralized bone matrix.
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Fig. 1.

Control macrophages attached to a devitalized bone
surface.

The cells are in various stages of the

spreading process (X 1000).
Fig. 2.

High magnification of control macrophages demonstrating
numerous microvilli on the unapposed surface.

Many

filopodia as well as some larger lamellipodia are
,

present at the cell periphery (X3000).
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Fig. 3.

Con A-treated macrophages attached to bone, illustrating
the minimal cell-matrix interaction (X 1000).

Fig. 4.

High magnification of con A-treated macrophages, as in
fig. 3.

The surface morphology demonstrates little

evidence of cell spreading.

The dorsal (unapposed)

surface has a ruffled appearance (X 3000).
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Fig. 5.

Field of SBA-treated macrophages attached to and
subsequently spreading on a bone surface.

The SBA does

not appear to inhibit the membrane-substrate interaction
(X 1200).

Fig. 6.

SBA-treated cells, as in fig. 5, at a higher
magnification.

Some cells exhibit an extensive

membrane-substrate interaction (single arrow), while
others are less advanced (double arrows) (X 2400).
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Fig. 7.

Quantitation of macrophage attachment to bone.

The

number of con A-treated macrophages that attached to the
bone surface is significantly greater than the number of
control or SBA-treated cells (p( .001).
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Fig. 8.

45

Ca bone release assay.
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:!:.

±
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.06), 48h (1.00

± .06),

72h (1.01

T/C ratios; 24h (0.98 + .04), 48h (0.83
(0.72 + .09).
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CHAPTER VI
PROCESSING OF CONCANAVALIN A-RECEPTOR
COMPLEXES BY OSTEOCLASTS IN VITRO
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ABSTRACT

The osteoclast is a large multinucleate cell that is widely
accepted as the primary effector cell responsible for normal bone
resorption.

In a previous study, we demonstrated that concanavalin A

(con A) has a dose-dependent biphasic effect on the bone resorbing
capacity of osteoclasts using a

45

Ca bone-organ culture system; bone

resorption was stimulated at low concentrations and inhibited at high
concentrations.

The mitogenic property of con A in lymphocyte

cultures is well-documented, and therefore, con A has been used
extensively to study the manner in which lymphocytes and other
mononuclear cells process the cell-bound lectin.

In this study, we

have investigated the processing of con A-receptor complexes by
osteoclasts in culture, using con A-FITC to evaluate the
redistribution of cell-bound con A via epifluorescence microscopy and
using con A-ferritin to determine whether the lectin-receptor
complexes are internalized.

The osteoclasts were obtained from the

long bones of newborn rats and allowed to attach to glass coverslips
at 37°c.

Following attachment, the non-adherent cells were removed by

rinsing.

The adherent osteoclasts were pre-incubated in 50 pg/ml

con A-FITC or con A-ferritin at 4°C for 10 minutes, washed to remove
unbound con A, and incubated at 37°C for 15 or 30 minutes in the
absence of con A.

Positive controls were fixed immediately after
0

pre-incubation at 4 C; negative controls were pre-incubated in
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con A-FITC and o{-methyl mannoside, the haptenic inhibitor of con A
binding.

The results demonstrate that redistribution and endocytosis

of con A-receptor complexes occurs within 30 min.

These findings

confirm the hypothesis that cell-bound con A can alter the structure
and activity of osteoclast membrane components in a manner similar to
that observed in mononuclear cell cultures.

The internalization of

con A may be important in altering osteoclastic activity by mediating
intracellular mechanisms involved in the bone resorbing process.
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INTRODUCTION

Lectins are proteins that have been used in a variety of
biological assays to study the surface structure and function of cells
and tissues.

Based on hapten inhibition studies which demonstrate

that the interactions of lectins with cells can be inhibited by simple
sugars, lectins are highly specific in their cell surface saccharide
binding requirements (Sharon and Lis, 1972).

In addition, many

lectins exhibit differential binding affinities for various mammalian
cells due to cell-specific differences in the expression of membrane
glycoconjugates.

These properties promote the use of lectins as

probes to study the structure and activity of cell surface components
in both normal and pathologically-altered tissues.

In biological

assays, lectins have demonstrated the ability to mimic the functional
effects of documented, physiological mediators of cellular activity,
such as hormones and lymphokines.

Therefore, lectins have been used

as in vitro model systems to evaluate the mechanisms of cellular
activation and/or inhibition.
A variety of agents, including certain lectins, such as
concanavalin A (con A), phytohemagglutinin (PHA) and pokeweed mitogen
(PWM), are capable of activating DNA and RNA synthesis in cultured
lymphocytes (Janossy and Greaves, 1972).

Subsequent to the binding of

these mitogenic lectins, the lymphocytes undergo a sequence of
morphological and metabolic transitions culminating in the formation
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of blast-like cells.

In addition, the mitogenic lectins are

particularly useful since they are capable of activating cell division
in a large, heterogeneous population of resting lymphocytes, in
comparison to the mitogenic capacity of specific antigens that can
only activate cell division in a small subpopulation of sensitized
lymphocytes (Takada et al., 1983).

This mitogenic property created a

surge of interest in the use of lectins in the early 1970's, to study
the morphological and biochemical events involved in the conversion of
a resting cell into an active, dividing cell.
Con A is the most widely used lectin in biological assays and its
mitogenic property in lymphocyte cultures has been well-documented.
Therefore, con A has been used extensively to study the manner in
which lymphocytes process cell-bound mitogenic lectins.

Studies by

Unanue et al. (1972), Yahara and Edelman (1973) and Bhalla et al.
(1979) have demonstrated that con A bound to lymphocyte surface
receptors can induce patch and cap formation of its own receptor sites
under certain conditions of incubation.

The endocytosis of

con A-receptor complexes following cap formation has also been
described (Unanue et al., 1972; Bhalla et al., 1979).

The formation

of lectin-receptor caps and their subsequent internalization are
metabolically dependent events (Yahara and Edelman, 1973; Ryan et al.,
1974; dePetris, 1975).

It has been postulated that the processing of

lectin-receptor complexes subsequent to lectin binding is necessary
for mitogenic activation of lymphocytes (Taylor et al., 1971; Greaves
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et al., 1972).
Aside from the mechanisms involved in lectin-cell surface
interactions, the biological effects of many lectins on a variety of
cellular systems have been investigated both in vivo and in vitro.
However, few studies have used lectins to evaluate the structure and
function of the skeletal system.

Wang et al. (1982) demonstrated that

the in vivo administration of PHA-P caused a significant increase in
the number and size of osteoclasts.

Horton et al. (1982) demonstrated

a decrease in resorption of long bones cultured in the presence of
high concentrations of con A (50 and 100 pg/ml).

Subsequent TEM of

these con A-treated osteoclasts revealed ultrastructural changes
associated with inhibition of osteoclastic activity (Ryder et al.,
1982).
The studies involving the skeletal system indicate that some
lectins can induce changes in the structure and function of bone
cells, particularly osteoclasts.

The osteoclast is a large

multinucleate cell that is widely accepted as the primary effector
cell responsible for normal bone resorption (Marks, 1983).

Although

the definitive origin of the osteoclast remains uncertain, there is
abundant evidence to support the hypothesis that osteoclasts are
derived from mononuclear cells of hemopoietic origin, possibly of the
monocytic lineage (Walker, 1975, Marks and Walker, 1981, Schneider and
Byrnes, 1983).

In a previous study, we demonstrated that the plasma

membrane of resident osteoclasts on the endocranial surface of rat
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calvariae possess specific binding sites for con A (Popoff and
Schneider, 1983).

In addition, we conducted a series of in vitro

45

Ca

bone release assays to evaluate the effect of various concentrations
of con A on the bone resorbing capacity of osteoclasts.

The bone

mineral release assays demonstrated that con A has a biphasic effect
on osteoclastic activity; at a low concentration (0.1 µg/ml) con A
increased bone resorption, whereas at higher concentrations (50 and
100 pg/ml) con A inhibited bone resorption.

We concluded that con A

may directly alter osteoclastic activity subsequent to its binding to
specific membrane glycoconjugates.

Alternately, con A may mediate

osteoclastic activity indirectly, through the intermediary of another
cell type.

These mechanisms of action have been proposed for other

endogenous agents that regulate osteoclastic activity (Rodan and
Martin, 1981; Chambers and Magnus, 1982; Chambers and Dunn, 1983).
It has been well-documented that there are a variety of agents
that regulate osteoclast function both in vivo and in vitro.

Although

the morphological changes associated with the stimulation or
inhibition of osteoclastic activity have been well-documented (King et
al., 1978; Holtrop et al, 1979; Wezeman et al., 1979), the nature of
the intracellular mechanisms responsible for these changes is poorly
understood.

Therefore, the use of an exogeneous biologically active

agent, such as con A, in conjunction with a bone organ culture system,
is of interest as an in vitro model to study the biological control of
osteoclast function.

Since many of the biological activities of con A
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appear to involve the initial binding of con A to the cell surface,
the fate of the cell-bound con A has been the focus of numerous
investigations.

In this study, we investigated the processing of

con A-binding site complexes by osteoclasts in vitro.

Con A

conjugated to fluoresceinisothiocyanate (con A-FITC) was used to
evaluate the redistribution of cell-bound con A via epifluorescence
microscopy.

In addition, an ultrastructural study using con A-

ferritin was conducted to determine whether these lectin-receptor
complexes are internalized.
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MATERIALS AND METHODS

!,reparation of osteoclasts
The procedure used to obtain osteoclasts from neonatal rat long
bone is similar to that described by Chambers et al. (1984).

Newborn

Norway Hooded rats (less than 24 hr) were sacrificed and the femurs
and tibias were removed and dissected free of soft tissue.

The long

bones were cut across at their epiphyses to separate the bony
diaphyses from the cartilaginous ends.

The four diaphyses obtained

from each rat were then placed into shallow (2 mm) glass wells of a
Boerner test slide containing approximately 500 ul of Medium 199
supplemented with 10% fetal bovine serum and 1% penicillinstreptomycin.

The bones were curetted with a scalpel and the

resulting suspension of cells and bone fragments was agitated and then
pipetted onto a 22 mm glass coverslip using a siliconized glass
pipette.

The cells were incubated for 1 hour at 37°c.

The

non-adherent cells and bone fragments were removed by thoroughly
washing the coverslips in 0.05M Tris buffer.

The coverslips were

examined via phase contrast microscopy and osteoclasts were identified
on the basis of their multinucleation, since these are the only
multinucleate cells in normal bone.

This procedure yields an average

of 80 osteoclasts per 4 long bones and a sparse population of attached
mononuclear cells.

Chambers et al. (1984) have shown that the long

bones from newborn animals reduces the presence of contaminating
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mononuclear cells in these osteoclast cultures, since the cellular
component of the bone marrow is poorly developed at this age.

The

following epifluorescent (con A-FITC) and ultrastructural (con Aferritin) experiments were performed on the attached osteoclasts
within a few hours.

Phase contrast - epifluorescence microscopy
Eight coverslips were used for this experiment.

The conditions

of incubation employed in this study have been used to study the
redistribution of cell-bound con A-FITC in mononuclear cell cultures
(Unanue et al., 1972; Yahara and Edelman, 1973; Bhalla et al., 1979).
The osteoclasts were pre-incubated in 0.05M Tris buffer containing
0

50 µg/ml con A-FITC (E-Y Labs, San Mateo, Ca.) for 10 minutes at 4 C.
The Tris buffer used in all of our procedures was supplemented with
O.lH NaCl and O.OlH CaC1

2

and adjusted to a pH of 7.2 to 7.4.

To

insure specific binding of tetravalent con A to cell surface
glycoconjugates, both divalent calcium ions and a narrow pH range from
7.0 to 7.4 are required (Sharon and Lis, 1972).

The osteoclasts on 2

of the coverslips were negative controls that were pre-incubated in
50 µg/ml con A-FITC and
con A binding.

-methyl mannoside, the haptenic inhibitor of

Following pre-incubation, the cells were sequentially

rinsed to remove unbound con A-FITC molecules.

After washing, the

cells on 2 of the remaining 6 coverslips and the negative controls
were fixed in 2.5% glutaraldehyde for 15 minutes.

The osteoclasts on
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the remaining 4 coverslips were incubated in supplemented Medium 199
at 37°C in the absence of con A for 15 or 30 minutes prior to
fixation.

Following fixation, all coverslips were inverted and placed

onto glycerol-coated glass slides.

The osteoclasts were immediately

examined with a Leitz Orthoplan epifluorescence microscope.

Transmission electron microscopy
The procedure for pre-incubation (4°C) and incubation (37°C) of
osteoclasts with con A-ferritin was identical to that used for
con A-FITC with the following exception.

The negative controls were

pre-incubated in 50 µg/ml native ferritin (Sigma, St. Louis, Ho.) at
4°C for 10 minutes in the absence of con A to demonstrate the
specificity of the conjugated ferritin label for cell-bound con A.
Following pre-incubation in 50 µg/ml con A-ferritin (E-Y Labs, San
0

Mateo, Ca.) at 4 C for 10 minutes, the cells were rinsed and the
osteoclasts on 2 coverslips were fixed immediately, while the
remaining osteoclasts were incubated in supplemented Medium 199 at
37°C in the absence of con A for 15 or 30 minutes.

Following fixation

in 2.5% glutaraldehyde for 15 minutes, the cells were rinsed and
post-fixed in 1% osmium tetroxide for 15 minutes.

The cells were

dehydrated through a graded series of ethanol and placed into
propylene oxide for 2 changes at 10 minutes each.

The cells were

infiltrated in a mixture of propylene oxide and Epon 812 and embedded
in beam capsules.

After the epoxy resin polymerized, the beam
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capsules and attached coverslips were immersed in liquid nitrogen.
The coverslips were snapped free of the Epon capsule which resulted in
a smooth surface on one end of the capsule containing the monolayer of
cells.

The cells were sectioned parallel to the plane of attachment.

A single l µm thick section was cut from the smooth block face and
stained with toluidine blue for light microscopy.

Thin sections

displaying silver or gold interference colors (60-80 nm thickness)
were obtained using a diamond knife on an LKB Ultratome V.

The

ultrathin sections were collected on 200 mesh thin-bar grids, stained
with uranyl acetate and lead citrate for 2 minutes each and examined
using a Hitachi H600 electron microscope.
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RESULTS

Phase contrast - epifluorescence microscopy
Osteoclasts attached to glass coverslips were easily identified
via phase contrast microscopy on the basis of their multinucleation.
0

Control osteoclasts that were labeled with 50 pg/ml con A-FITC at 4 C
for 10 minutes exhibit a fluorescence that is evenly distributed over
the entire cell surface (Fig. 1).

Frequently, the fluorescence at the

perimeter of the cell is accentuated, thereby outlining the peripheral
extent of these attached cells (Fig. 1).

A faint fluorescence over

the filopodia extending from the periphery can also be observed.

The

negative control osteoclasts that were labeled at 4°C in the presence
of 50

~g/ml

con A-FITC and 0.1 H ~-methyl mannoside, the specific

inhibitor of con A-ligand binding, do not exhibit any fluorescence
(Fig. 2).

These negative controls indicate that the binding of

con A-FITC to osteoclast membrane glycoconjugates containing «-linked
D-glucose and D-mannose residues is specific.
The osteoclasts that were rinsed and incubated at 37°C for 15
minutes in the absence of con A following cold labeling with
con A-FITC, demonstrate a localization of membrane fluorescence that
is confined to the central, nuclear area of the cells (Fig. 3).

The

membrane peripheral to the nuclear region and the peripheral membrane
specializations, such as lamillipodia and filopodia, showed minimal
fluorescence.

The fluorescent "caps" observed in the 15 minute
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osteoclasts have an uneven or patchy appearance in comparison to the
fluorescence observed on control osteoclasts.

Some areas of the "cap"

fluoresce brightly while other areas fluoresce less intensely.

The

size of the fluorescent "caps" varied depending upon the degree to
which the cells were spread; the "caps" were smaller in those
osteoclasts that were spread more extensively.

The osteoclasts that

0

were rinsed and incubated at 37 C for 30 minutes in the absence of
con A following pre-incubation with con A-FITC also exhibit a
fluorescent pattern that is observed in the central regions of the
cells (Fig. 4).

However, in comparison to the 15 minute osteoclasts,

the fluorescence after 30 minutes is more evenly distributed and
occupies a larger area, thus extending further out toward the
periphery.

In addition, the negative images of the nuclei are clearly

visible suggesting that at 30 minutes some fluorescent label is
located in the cytoplasm of these cells (Fig. 4).

Transmission electron microscopy
By transmission electron microscopy (TEM), the cultured
osteoclasts possessed many of the ultrastructural features that have
been well-documented for osteoclasts apposed to bone in vivo (Holtrop
and King, 1976)(Fig. 5).
from 5 to 20 per cell.

The nuclei in 1 um sections range in number
Most of the nucleoplasm is euchromatic with a

peripheral clumping of heterochromatin along the inner nuclear
membrane.

The cytoplasm is densely populated with pleomorphic

124
mitochondria.

Dense bodies and vacuoles of various sizes are also

uniformly scattered throughout the cytoplasm.

Numerous investigators

have described these dense bodies in the osteoclast and have
associated them with the lysosomal system of the osteoclasts (Lucht,
1972; Thyberg et al., 1975).

In addition, some of the osteoclasts

remain attached to fragments of bone surrounded by an organelle-free
region of the cytoplasm, the clear zone (Fig. 5).
The control osteoclasts that were pre-incubated at

4°c

with

50 pg/ml con A-ferritin exhibit an even distribution of ferritin
particles along the entire outer leaflet of the plasmalemma (Figs. 6 &
7).

There is no evidence of internalization of the ferritin label in

these control osteoclasts.

In contrast, the osteoclasts that were
0

0

first labeled with con A-ferritin at 4 C and then incubated at 37 C
for 15 minutes in the absence of con A, demonstrate active endocytosis
of the con A-ferritin receptor complexes (Fig. 8).

Some areas of the

membrane show tubular invaginations forming a system of canaliculi
that are continuous with the cell surface (Figs. 8 & 9).
Clathrin-coated pits are also frequently observed along the
plasmalemma (Fig. 10).

The ferritin label is concentrated in these

caniliculi and coated pits (Figs. 9 & 10).

The plasmalemma

surrounding these membrane specializations is either devoid of label
or sparsely labeled in an uneven fashion.

In addition, some endocytic

vesicles (endosomes) labeled with ferritin are found in the cytoplasm
immediately underlying the cell surface (Fig. 8).

Frequently,
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channels containing the ferritin label are also observed in areas of
the cytoplasm that do not exhibit continuity with the cell surface.
This indicates that the canalicular system may be more extensively
developed than is apparent from the tubular invaginations that show
continuity with the cell surface.

In the osteoclasts incubated at

0

37 C for 30 minutes, most of the ferritin label is found in the
cytoplasm, primarily in endosomes and occasionally in channels (Fig.
11).

The ferritin labeling density within the vesicles and the size

of the vesicles vary considerably.

Frequently, smaller endosomes

appear to be fusing with larger ones (Fig. 11).

Some of the channels

within the cytoplasm are also continuous with the larger endosomes.
0

Osteoclasts that were pre-incubated in 50 µg/ml native ferritin at 4 C
in the absence of con A, do not exhibit a ferritin label along their
cell surface.

This indicates that the conjugated ferritin label is

specific for membrane-bound con A.
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DISCUSSION

In the early 1970's, the mitogenic property of certain lectins,
such as con A, PHA and PWM, created an interest in the use of these
lectins to study blast transformation in resting lymphocyte cultures.
Many of the ensuing investigations that focused on the morphological
and biochemical events involved in the activation of cell division
used con A as the lymphocyte activating agent because it offered a
number of attractive features as a biological probe.

Con A is a

well-defined tetravalent protein that specifically binds to cell
surface glycoconjugates containing
residues.

~-linked

D-glucose and D-mannose

The haptenic inhibitor of con A binding, o<-methyl

mannoside, is used in control cultures to demonstrate the specificity
of con A binding to cell surface receptors.

A variety of con A-

conjugates are commercially available in high purity and can be used
to visualize membrane-bound con A via ultrastructural and cytochemical
techniques.
Con A is the most widely used lectin in biological assays and it
has been used extensively to study the manner in which lymphocytes
process cell-bound mitogenic agents.

Unanue et al. (1972) used

con A-FITC to demonstrate that patching and capping of con A binding
0

sites occurred when lymphocytes were labeled with con A at 4 C, then
washed to remove unattached con A molecules, followed by incubation at
37°c.

Yahara and Edelman (1973) showed that lymphocytes incubated at
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37°C in concentrations of con A above 10 pg/ml did not exhibit patch
or cap formation, whereas at concentrations below 10 pg/ml some of the
lymphocytes capped.

These observations were confirmed by Bhalla et

al. (1979), who demonstrated that if washing is omitted after
0

pre-incubation at 4 C or if con A is added back to the medium after
washing, the percentage of cells forming caps is drastically reduced.
Once the caps are formed, the con A-receptor complexes are rapidly
endocytosed (Unanue et al., 1972; Bhalla et al., 1979).

The formation

of lectin-receptor caps and their subsequent internalization are
metabolically dependent events (Yahara and Edelman, 1973; Ryan et al.,
1974; dePetris, 1975).

It has been postulated that the redistribution

and endocytosis of cell-bound con A may be necessary events for
mitogenic induction in lymphocyte cultures (Taylor et al., 1971;
Greaves et al., 1972).
The results of the con A-redistribution studies indicate that
depending on the conditions of incubation employed, con A exhibits 2
antagonistic properties when bound to lymphocytes; it can induce or
inhibit cap formation of its own binding sites.

To induce cap

formation of con A-receptor complexes it is necessary to wash the
cells following pre-incubation with con A to remove unbound con A
molecules.

In this study we have demonstrated the redistribution of

con A-receptor complexes in cultured osteoclasts in a manner similar
to that described for lymphocytes and other mononuclear cells.
osteoclasts that were pre-incubated with con A-FITC and -'-methyl

The
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mannoside do not fluoresce when examined via epifluorescent
microscopy.

This indicates that the fluorescent label is specific for

con A binding sites on the osteoclast membrane.

The positive controls

that were fixed immediately after pre-incubation with con A-FITC at
4 0 C, exhibit a fluorescent pattern suggesting that the cell-bound
con A is evenly distributed over the entire cell surface.

When the

cells were washed to remove the unbound con A molecules following
pre-incubation at 4 0 C and subsequently wanned to 37 0 C for 15 minutes
in the absence of any con A in the culture medium, the con A-binding
site complexes had moved to occupy the membrane overlying the
centrally located nuclei, visualized by the central localization of
con A-FITC.

This movement is similar to the fonnation of

ligand-receptor caps in adherent mononuclear cell cultures.

Although

the intensity of the fluorescence in these osteoclast "caps" was
greater than the intensity in the control osteoclasts, the fluorescent
pattern within each "cap" was uneven.

The cells that were washed and

0

incubated in con A free-medium at 37 C for 30 minutes, exhibit a
cytoplasmic localization of the fluorescent label as evidenced by the
negative nuclear images.

The cytoplasmic fluorescence observed in the

30 minute osteoclasts suggests that the con A-receptor complexes have
been endocytosed.
The plasma membrane of most animal cells contains a variety of
specific receptors for external macromolecular ligands, including
hormones, vitamins, lymphokines and pathological agents, such as
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bacterial toxins and viruses.
glycoproteins.

Most of the surface receptors are

The induction of many of the functional effects by

cell-specific ligands requires the internalization of the
receptor-bound ligands.

Subsequent to ligand binding, the endocytosis

of the ligand-receptor complexes is rapid and highly specific
(Willingham and Pastan, 1984).

The general pathway of endocytosis

involves the clustering of ligand-receptor complexes in
clathrin-coated pits along the plasma membrane.

The coated pits pinch

off from the membrane, thus forming intracellular endocytic vesicles
(endosomes).
Since lectins bind specifically to cell surface glycoproteins and
subsequently enter cells via the endocytic cycle, they have been used
to study the mechanisms of endocytosis in cell cultures (Gonatas et
al., 1980; Welsch et al., 1982; Welsch and Schumacher, 1983).

In this

study we used con A conjugated to ferritin to determine whether
osteoclasts are capable of internalizing cell-bound con A.

We

performed a preliminary study to determine what concentration of
con A-ferritin would give us a sufficient ferritin label so that we
could accurately assess the redistribution and endocytosis of
cell-bound con A-ferritin.

From this study, we found that a

concentration of 50 pg/ml was optimal.

The control cells that were

fixed immediately after pre-incubation at 4°C with con A-ferritin
demonstrate a uniform ferritin label along the cell surface.
0

The

osteoclasts that were pre-incubated at 4 C, washed and incubated at

130
37 0 C for 15 minutes exhibit a clustering of ferritin in coated pits
and in tubular invaginations of the cell surface.

In addition,

ferritin-labeled vesicles are present in the cytoplasm subjacent to
the cell surface.

The system of canaliculi in these osteoclasts forms

in response to the processing of cell-bound con A, since tubular
profiles are absent in the control cells.

In addition, these

canaliculi have not been described by other investigators who have
examined the ultrastructure of cultured osteoclasts Allen et al.,
1981; Testa et al., 1981; Suda et al., 1983).

Although the continuity

between the cell surface and some of the tubular invaginations is
clearly evident, we frequently observed sections of ferritin labeled
tubules that did not exhibit continuity with the cell surface.
Therefore, the complexity of this tubular labyrinth cannot be
determined from our ultrathin sections.

Abe et al. (1981) showed that

the examination of thick sections (1.0 - 1.5 pm) of macrophages by
high voltage electron microscopy provides an image with
three-dimensional features of the cell surface configuration.
Employing this procedure to examine thick sections would enable us to
establish the complexity of the canalicular system in these
osteoclasts.

The changes we observed in the structure and activity of

the osteoclast membrane in this study were induced by the cell-bound
con A and not the ferritin.

This conclusion is based on the

observation that osteoclasts pre-incubated with native ferritin at 4°C
do not bind the ferri tin molecule.
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0

In the osteoclasts that were incubated at 37 C for 30 minutes
0

following the 4 C pre-incubation with con A-ferritin, the ferritin
label is primarily located intracellularly contained within endosomes.
Occasionally, the ferritin label is also observed within tubular
profiles.

Frequently, the larger ferritin-labeled endosomes are

surrounded by smaller ferritin-labeled vesicles, some of which appear
to be fusing with the larger endosomes.

Although we were able to

observe a spatial relationship between ferritin-labeled endosomes and
the lysosomes, the lysosomal contents and the ferritin label are
similar in density, and therefore, ferritin cannot be visualized
within the lysosomes.

To determine whether the endocytosed con A-

ferritin is ultimately routed into the lysosomes, possibly via the
Golgi apparatus as described in some cell types, a study employing a
different con A conjugate, such as con A-colloidal gold, should be
conducted.
Ultrastructural studies by Takata et al. (1984) and Abe et al.
(1979) demonstrated that murine peritoneal macrophages possess an
extensive three-dimensional tubular labyrinth underneath the cell
surface.

These channels are continuous with the cell surface.

This

tubular labyrinth appears similar to the tubular profiles we observed
in the osteoclasts, with the exception that the macrophage tubular
network even exists in cells that are not exposed to a specific
ligand.

In a recent study by Takata et al. (1984), they demonstrated

the redistribution and endocytosis of con A-receptor complexes in
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murine peritoneal macrophages.

They labeled macrophages with 50 pg/ml

con A-colloidal gold at 0°c, washed the cells and warmed them to 37°c.
This resulted in the movement of con A-receptor complexes into the
tubular network beneath the cell surface.

The subsequent localization

of colloidal gold in endosomes verified the endocytosis of con Areceptor complexes.

They concluded that the tubular labyrinth is

involved in the processing of cell-bound con A by these macrophages.
Since the phenomenon of capping was originally described in 1971
by Taylor et al. on B lymphocytes in suspension, its relation to cell
motility and the endocytic cycle has been studied on cells attached to
a substrate.

Surface receptors are cross-linked by a specific ligand

resulting in the formation of small two-dimensional aggregates of
ligand-receptor complexes called patches.

If a cell is motile, the

patches will move to and cap in a region of the cell membrane that is
remote from the cell's leading edge of attachment and migration.

The

process of cap formation in migrating mononuclear cells that exhibit a
bipolar structural organization is well documented {dePetris and Raff,
1972; Edidin and Weiss, 1972; dePetris and Raff, 1973; Vasilieu et
al., 1976).

Bretscher {1984) described a model of membrane flow that

relates the process of cap formation with the endocytic cycle in
migrating cells.

On

the cell surface, membrane components flow from

the cell's leading edge to the rear of the cell, the region that
corresponds to the eventual site of cap formation.

Patches of

ligand-receptor complexes exhibit a preferential mobility resulting in

133
cap formation.

The subsequent endocytosis of the capped

ligand-receptor complexes results in a large amount of plasma membrane
that is being internalized and must be recycled back to the cell
surface.

According to Bretscher's model, this internal membrane pool

is transported through the cell and reinserted into the plasma
membrane at the cell's leading edge.

In this study, the osteoclasts

are spreading evenly in all directions on the substrate, and therefore
do not exhibit a bipolar organization.

In these cells the leading

edge occurs along the entire cell perimeter.

According to the

membrane flow hypothesis, the cross-linked con A-receptor patches
should move away from the free edge toward the center of the cell.
Our observations on the localization of cell-bound con A-FITC
coincides with this hypothesis.

Endocytosis of the cell-bound lectin

results in the internalization of large amounts of plasma membrane
which may then be transported through the cell to be reinserted at the
leading edge.

Although the phenomena of capping and endocytosis have

been studied in relation to one another, capping of ligand-receptor
complexes is not a necessary prerequisite for endocytosis.
Endocytosis can occur in the absence of cap formation and it may also
occur during cap formation.
There are a variety of physiological agents that are capable of
altering the bone resorbing activity of osteoclasts both in vivo and
in vitro.

These include parathyroid hormone (PTH) and calcitonin

(CT), the two primary hormones regulating osteoclastic activity in
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vivo.

In addition studies have demonstrated that osteoclast

activating factor, a lymphokine produced by activated lymphocytes,
several prostaglandins, 1,25 dihydroxyvitamin

n3

and interleukin-1 can

stimulate bone resorption in vitro (Klein and Raisz, 1970; Raisz et
al., 1972; Horton et al., 1974; Gowen et al., 1983).

Some of these

agents (i.e. CT) bind directly to specific osteoclast membrane
receptors (Warshawsky et al., 1980; Roa et al, 1981; Chambers and
Magnus, 1982), while others (i.e. PTH) lack specific receptors on the
osteoclast membrane (Silve et al., 1982; Chambers and Dunn, 1983).
These results support the hypothesis that some biologically active
ligands may act directly on osteoclasts, while others may regulate
osteoclastic activity indirectly through the intermediary of another
cell type (Rodan and Hartin, 1981; Chambers and Dunn, 1983).

In a

previous study, we demonstrated specific con A binding sites on the
osteoclast membrane (Popoff and Schneider, 1983).

We also showed that

con A has a dose-dependent biphasic effect on the bone resorbing
capacity of osteoclasts using a

45

Ca bone organ culture system.

The ultrastructural changes associated with the stimulation or
inhibition of osteoclastic activity have been well-documented both in
vivo (Holtrop et al., 1979) and in vitro (King et al., 1978; Wezeman
et al., 1979).

However, the manner in which the osteoclast processes

ligand-receptor complexes subsequent to the binding of a functional
ligand and the intracellular mechanisms responsible for changes in
cell activity are poorly understood.

Under the proper conditions of
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incubation, we have shown that cell-bound con A causes an alteration
of membrane structure and activity in cultured osteoclasts.

The

processing of con A-receptor complexes includes the redistribution and
endocytosis of cell-bound con A in a manner similar to that described
in a variety of mononuclear cell cultures.

These metabolically

dependent events may represent a general mechanism that is used by the
osteoclast to process other endogenous mediators of physiological
function that directly bind to specific membrane receptors.

The

endocytosis of ligand-receptor complexes may regulate intracellular
events that ultimately results in an increase or a decrease in
osteoclastic activity.
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Fig. 1.

a) Phase contrast of an osteoclast pre-incubated with
con A-FITC at 4°C prior to fixation (X 600).
b) corresponding fluorescent image demonstrating a
fluorescent label that is evenly distributed over the
entire cell surface.

Fig. 2.

a) Phase contrast of an osteoclast pre-incubated with
0

con A-FITC ando<-methyl mannoside at 4 C (X 600).
b) the fluorescent image demonstrates a lack of

.i

lluorescent label associated with the osteoclast.
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Fig. 3.

a) Phase contrast of 2 osteoclasts pre-incubated in
0

0

con A-FITC at 4 C, washed, and incubated at 37 C for
15 min {X 600).

b) the fluorescent images demonstrate

central localization of the membrane-bound label.
Fig. 4.

a) Phase contrast of an osteoclast incubated at 37°c
for 30 min. following pre-incubation with con A-FITC
at 4°C {X 600).

b) the negative images of the nuclei

suggest that the fluorescent label is located inside the
lell.
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Fig. 5.

Portion of a cultured osteoclast that exhibits
cytoplasmic features characteristic of osteoclasts.
The cytoplasm contains many pleomorphic mitochondria,
vacuoles and dense bodies.

n - nucleus;

ec - extracellular space; b - bone fragment;
cz - clear zone (X 5500).
Fig. 6.

Cell surface of an osteoclast pre-incubated with
con A-ferritin prior to fixation.

The ferritin label is

evenly distributed along the outer aspect of the plasma
membrane (X 40,000).
Fig. 7.

i

'High magnification of the cell membrane of a control
osteoclast.

This tangential section demonstrates the

even distribution of ferritin particles (X 80,000).
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Fig. 8.

Portion of an osteoclast incubated at 37°c for 15 min
0

after pre-incubation with con A-ferritin at 4 C.

The

ferritin label at the cell surface is concentrated in
the tubular invaginations of the plasmalemma.

There are

also some ferritin-labeled endocytic vesicles (arrows)
within the cytoplasm (X 40,000).
Fig. 9.

High magnification of a tubular invagination from the
osteoclast in Figure 8, demonstrating the localization
of the ferritin label (X 120,000).

Fig. 10

High magnification of a coated pit at the surface of a

1! min.

osteoclast.

The ferritin label is confined to

the coated pit area, while the surrounding membrane is
free of label (X 120,000).
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Fig. 11

Cytoplasm of an osteoclast incubated at 37°c for 30 min.
0

after con A-ferritin pre-incubation at 4 C.

Ferritin-

labeled endosomes of various sizes {solid arrows) and
occasional ferritin-labeled tubules {open arrows) are
present in the cytoplasm {X 50,000).
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CHAPTER VII

DISCUSSION

Lectins have been used in a variety of biological assays to study
the surface structure and function of cells and tissues.

However, few

studies have used lectins to evaluate the structure and function of
the skeletal system.

Wang et al. (1982) demonstrated that the in vivo

administration of PHA-P caused a significant increase in the number
and size of long bone osteoclasts.

Horton et al. (1982) demonstrated

a decrease in resorption of long bones cultured in the presence of
high concentrations of con A (50 and 100 µg/ml).

Subsequent TEM of

these con A-treated osteoclasts revealed ultrastructural changes
associated with inhibition of osteoclastic activity (Ryder et al.,
1982).
The studies involving the skeletal system indicate that some
lectins are capable of inducing changes in bone cells, particularly
osteoclasts.

Therefore, we were initially interested in demonstrating

the existence of specific con A binding sites on the surface of
osteoclasts and in evaluating the functional effects of various
concentrations of con A on bone resorption and osteoclastic activity.
For these studies we used the calvariae of 10-day old rats for the
following reasons.

The distribution of osteoclasts and osteoblasts on
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the endocranial surface of the flat bones of the growing rodent skull
is well-documented and the number of osteoclasts reaches its peak at
approximately 10-days post-partum (Barnicott, 1947; Jones and Boyde,
1976; Jones and Boyde, 1977; Abe et al., 1983).

In addition, the

culture of these calvarial bone-organ explants is a resorbing culture
system that can be used as an in vitro model to quantitatively
evaluate the functional effects of con A on resident osteoclasts
attached to their natural substrate.
The culture of bone-organ explants such as calvariae is an organ
culture system in which the resorption of bone occurs without the
addition of any stimulating agents.

The fetal bovine serum that is

used to supplement the tissue culture medium contains a variety of
serum components, some of which are probably capable of influencing
osteoclastic bone resorbing activity.

The release of

45

ca from

pre-labeled calvariae can be quantitated with respect to the total
amount of
percent of
percent

45

45

Ca initially present in each calvaria, yielding the

45

Ca

released over a specified period of time.

The average

ca release from calvariae that have been devitalized and

cultured in BGJb medium for a period of 72 hrs. (dead bone release) is
3.1

.±

0.4% (fig. 1).

In comparison, the average percent

45

Ca release

from live calvarial explants cultured under identical conditions for
72 hrs. (live bone release) is 11.2

.±

0.6% (fig. 1).

The difference

of approximately 8.2% is due to the resident cellular component which
is eliminated from the calvarial explants by devitalization.

The
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cellular component is primarily composed of the 3 bone cell types:
namely osteoclasts, osteoblasts and osteocytes.

Other mononuclear

cells, such as macrophages and periosteal fibroblasts, also constitute
a small fraction of the cells present in normal calvariae.

The

osteoclast is widely accepted as the primary effector cell responsible
for normal bone resorption (Harks, 1983).

Therefore, the osteoclasts

are largely responsible for the cell-mediated
bone-organ cultures.
capable of mobilizing
release of

45

45

Ca release in the live

However, the other resident cells are also
45

Ca and they may also contribute to the overall

Ca from the live bone-organ cultures. (Rodan and Hartin,

1981; Hamilton et al., 1984; Heath et al., 1984; Otsuka et al., 1984).
Using con A and hemocyanin, a marker molecule used to visualize
cell-bound con A via SEH, we demonstrated that resident calvarial
osteoclasts have specific binding sites for con A on their cell
surface.
using

The specificity of these con A receptors was determined by

~-methyl

mannoside, the haptenic inhibitor of con A binding, in

control cultures.

A series of

45

ca bone release assays were conducted

using pre-labeled calvariae to determine whether or not con A, at
various concentrations, has any effect on

45

Ca release.

The ability

of osteoclasts to resorb bone was determined by the amount of

45

Ca

released into the tissue culture medium during three 24 hr. periods
after the release of labile

45

ca.

The results demonstrate that con A

has a dose-dependent biphasic effect on the bone resorbing capacity of
osteoclasts; at a low concentration (0.1 µg/ml) con A increased bone
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resorption, whereas at higher concentrations (50 and 100 pg/ml) con A
inhibited bone resorption.
reduction in the release of

We also showed that the con A-mediated
45

ca at 50 pg/ml is reversible, indicating

that con A is inhibitory rather than cytotoxic to osteoclasts at the
higher concentrations.
After observing the effects of con A, we were interested in the
effects of three other lectins, WGA, SBA and PNA, on
the calvarial culture system.

45

Ca release in

The four lectins, con A, WGA, SBA and

PNA, have cell surface saccharide binding specificities that are
distinctly different from one another.

All of the sugar residues to

which these four lectins bind are common to mammalian
membrane-associated glycoconjugates.

Another series of

45

ca bone

release assays were performed using a lectin concentration of 50 pg/ml
for each of the three lectins to be tested.
WGA inhibited the release of

45

ea,

At this concentration,

although its effect was not as

pronounced as that of con A at the same concentration.

On the

contrary, neither SBA nor PNA had any effect on bone resorption in
comparison with the control assay run in the absence of any lectin.
These findings indicate that the reduction in bone resorption mediated
by con A, and to a lesser extent WGA, at a concentration of 50 pg/ml
is not a generalized phenomenon that occurs subsequent to the binding
of any lectin at this concentration.

This conclusion would suggest

that the specificity of lectin binding to cell surface receptors is an
important factor in the induction of an alteration of cellular
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function that is mediated by a particular lectin.
There are a variety of agents that regulate osteoclastic activity
in vivo and in vitro.

These include the two primary hormones that

regulate osteoclastic function in vivo, PTH and CT.

In vitro a

variety of agents influence the ability of osteoclasts to resorb bone,
including the vitamin l,25(0H)
lymphokines OAF and IL-1.

n , several prostaglandins, and the

2 3

Numerous investigators have probed the

osteoclast membrane to determine whether or not specific receptors for
PTH and CT are present (Warshawsky et al., 1980; Rao et al., 1981;
Chambers and Dunn, 1982; Chambers and Magnus, 1982; Silve et al.,
1982; Chambers and Moore, 1983).

The results of these studies support

the hypothesis that some agents may act directly on osteoclasts (i.e.
CT), while others may regulate osteoclastic activity indirectly (i.e.
PTH) through the intermediary of another cell type (Rodan and Martin,
1981; Chambers and Dunn, 1983).

Although the ultrastructural changes

associated with the stimulation or inhibition of osteoclastic activity
have been well-documented both in vivo (Holtrop and King, 1976;
Holtrop et al., 1979) and in vitro (King et al., 1978; Wezeman et al.,
1979), the mechanisms responsible for changes in osteoclastic activity
are poorly understood.

Functional ligands that directly bind to

specific membrane receptors and subsequently alter cellular activity
can do so via two general mechanisms; the cell-bound ligand can
regulate cell function through an alteration of the cell surface
structure or the cell-matrix interaction (external mechanism), or the
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ligand-receptor complexes can be internalized (internal mechanism).
The external mechanism whereby a ligand can regulate a cellular
activity includes the following possiblities.

The binding of a

particular ligand to specific membrane receptors can either enhance or
inhibit the binding of another functional ligand to the cell surface.
In the con A-treated bone-organ culture system this is possible since
the tissue culture serum supplement contains a variety of components,
some of which are probably capable of regulating osteoclastic
function.

The ability of a particular ligand to influence the binding

of another functional ligand can only be evaluated in a culture system
in which all of the components of the culture medium are defined.

On

the other hand, in tissue and organ culture systems where a
morphological and functional interaction between the cells being
studied and the matrix to which the cells are attached is essential
for normal cell function, a cell-bound ligand may modify the
cell-matrix interaction thereby altering cell function.
It is well-documented that there is a morphological and
functional interaction between the osteoclast and the bone matrix that
f

is esential for normal resorptive activity to occur.

The clear zone

and ruffled border membrane specializations apposed to the bone matrix
are the ultrastructural hallmarks of active osteoclastic bone
resorption.

We were interested in evaluating the effects of 2

lectins, con A and SBA on the interaction between the osteoclast and
the bone matrix.

However, this type of experiment is technically
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impossible for a number of reasons.

The procedure would involve the

isolation of a pure population of osteoclasts in large numbers.

No

one to date has successfully isolated a pure population of
osteoclasts.

If it were possible to isolate osteoclasts in large

numbers the cells would then be treated with either con A or SBA and
allowed to attach to a devitalized bone surface.

However, osteoclasts

are extremely sensitive to any type of mechanical trauma and the
manipulation of thse cells required in this type of experiment would
probably result in cell death.

Even if it were possible to establish

a viable pool of osteoclasts attached to a devitalized bone surface,
the maintenance of these cells in long term culture and the ability to
quantitatively assess their capacity to resorb bone is, at best,
questionable.
Because of the difficulty in obtaining pure populations of
osteoclasts, most studies on bone resorption are performed on intact
animals or bone-organ cultures.

These sytems do not permit detailed

analysis of cellular mechanisms of bone resorption or of the means
whereby resorbing cells attach to the bone surface (Teitelbaum et al.,
1979).

Since monocytes and macrophages are capable of attaching to

and subsequently resorbing devitalized bone in vitro (Mundy et al.,
1977; Kahn et al., 1978; Teitelbaum et al., 1979), the
macrophage-devitalized bone culture system serves as a useful model to
study the morphological and functional interaction between the
resorbing macrophages and the bone matrix.

The studies by Kahn et al.
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(1978) and Teitelbaum

~t

al. (1979) also demonstrated that optimal

macrophage-mediated mineral mobilization requires cell-matrix contact.
Recent studies by Bar-Shavit et al. (1983b,c,d) have demonstrated that
the attachment of macrophages to bone is a regulated process that is
mediated, in part, by certain saccharides located on the cell and/or
bone surfaces.

These findings indicate that the attachment of

resorbing macrophages to the bone matrix is an important component of
the process of bone resorption and that the oligosaccharide-mediated
binding mechanism that links the resorbing macrophages to bone is
essential for normal resorptive activity.
The importance of the cell-matrix interaction in the
macrophage-bone culture system justifies its use to evaluate the
effects of con A and SBA on the interaction between a bone matrix and
cells that are capable of attaching to and subsequently degrading it.
We chose these 2 lectins based on the results from the

45

Ca bone

release assays in which con A at a concentration of 50 pg/ml inhibited
bone resorption, whereas SBA had no effect on bone resorption at the
same concentration.

The results demonstrate that macrophages allowed

to attach to bone in the presence of con A exhibit a cell surface
morphology that is markedly different from that of control macrophages
as visualized by SEM.

Although the con A-treated macrophages do

attach to the bone surface, they are hindered in their ability to
spread on the substrate.

The membrane surface area that is apposed to

the bone surface in the con A-treated system is only one-half that of
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control cells.

The quantitative results demonstrate that

approximately twice the number of con A-treated macrophages attached
to the bone surface in comparison with the number of untreated cells.
Although these results seem to conflict with the

45

Ca functional data,

this quantitative difference is most likely the result of the
extensive aggregation of macrophages by con A.

The cross-linking of

cell membranes by con A may significantly increase the number of cells
that appear to attach to the bone matrix, since those cells that would
not attach under normal conditions appear to be attached to the bone
surface by cross-linking to the cells that are capable of attachment.
On the contrary, SBA does not appear to change the attachment and
subsequent spreading of macrophages on bone either morphologically or
quantitatively.
A series of

45

Ca bone release assays were conducted to determine

whether the morphological observations could be correlated to any
functional differences in the ability of con A-treated or SBA-treated
macrophages to release 45 ca in vitro.

The con A-treated

macrophage-bone samples demonstrated a significant decrease in mineral
mobilization at 48 and 72 hours, whereas the

45

Ca released from the

macrophage-bone samples in the presence of SBA did not differ
significantly from the control assay at any of the sampling time
points.
The results obtained from this macrophage-devitalized bone
culture system demonstrate that con A, but not SBA, alters the
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morphology and function of macrophages on a bone surface.

The

morphological findings support the hypothesis that specific
saccharides common to cell surface and/or matrix associated
glycoconjugates are involved in the macrophage-bone interaction.
Oligosaccharides containing ..(-linked D-glucose and D-mannose residues
are more likely to be involved in the macrophage-bone interaction,
than oligosaccharides containing GalNAc or D-galactose residues.

The

functional data suggest that the decreased surface area of cell-matrix
contact in the con A-treated cultures may, at least in part, account
for the reduction in macrophage-mediated mineral mobilization.
There also exists a correlation between the effects of con A and
SBA on bone mineral mobilization in the macrophage-bone cultures and
their effects on

45

Ca release in the bone-organ cultures.

At the

lectin concentration of 50 pg/ml, con A causes a reduction in the
release of

45

ca in both systems, whereas SBA has no effect on mineral

mobilization in either system.

In both culture systems, cell-matrix

contact and the subsequent functional interaction are important
components of the process of bone degradation.

Therefore, it is

possible that the con A-mediated inhibition of bone resorption in the
bone-organ culture system at higher concentrations may, in part, be
the result of the ability of cell-bound con A to interfere with the
interaction between the osteoclast and the bone matrix, an essential
prerequisite for normal resorptive activity.
When comparing these 2 culture systems it is important to use the
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term "resorption" corre.c tly.

The regulated process of normal bone

breakdown by osteoclasts is called bone resorption.

The ruffled

border and clear zone are ultrastructural hallmarks indicative of
active resorption of underlying bone by osteoclasts.

Although there

are similarities in the degradation of bone by macrophages, the
development of clear zones and ruff led borders have never been
demonstrated in the macrophage-bone culture system.

Therefore, when

referring to macrophage-mediated bone breakdown terms such as mineral
mobilization and bone degradation should be used and the word
"resorption" should be limited to the process mediated by osteoclas ts.
The induction of many of the functional effects by cell-specific
ligands requires the internalization of the cell-bound ligands.

The

internal mechanism that was alluded to earlier in this discussion
involves the processing of ligand-receptor complexes, including the
redistribution and endocytosis of these complexes.

Once the ligand

has been internalized it can follow a variety of intracellular
pathways thereby influencing one or more intracellular events that
will ultimately result in altered cell function.

A general summary of

the events related to receptor mediated endocytosis is schematically
presented in fig. 2.

Subsequent to ligand binding to specific

membrane receptors, the ligand-receptor complexes become clustered in
coated pits along the membrane.

These coated pits have a

clathrin-protein coat attached to the inner leaflet of the
plasmalemma.

The coated pits pinch off from the cell surface forming
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endocytic vesicles (endosomes) that rapidly lose their protein coat
which is recycled back to the cell surface.

The endosomes migrate

deeper into the cytoplasm and frequently fuse with one another.

At

some point along the intracellular pathway, the ligand-receptor
complex is dissociated and the receptors are usually recycled back to
the surface.

The intracellular routing of a particular ligand and the

ultimate localization of that ligand within a specific subcellular
compartment depends on the type of ligand that has been internalized.
The lysosomal system, nucleus and Golgi apparatus are frequent sites
of ligand localization.
Since many of the biological activities of con A appear to
involve the initial binding and subsequent processing of cell-bound
con A, the fate of the con A-receptor complexes has been investigated
in a variety of mononuclear cell cultures.

The mitogenic property of

con A in lymphocyte cultures is well-documented, and therefore, the
manner in which lymphocytes process cell-bound con A has been studied
extensively.

Studies by Unanue et al. (1972), Yahara and Edelman

(1973) and Bhalla et al. (1979) demonstrated that con A bound to
lymphocyte surface receptors can induce patch and cap formation of its
own receptors under certain conditions of incubation.

The endocytosis

of con A-receptor complexes following cap formation has also been
described (Unanue et al., 1972; Bhalla et al., 1979).

The capping and

endocytosis of ligand-receptor complexes are metabolically dependent
events (Yahara and Edelman, 1973: Ryan et al., 1974; dePetris, 1975).
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It has been postulated that the processing of ligand-receptor
complexes in these lymphocyte cultures is necessary for mitogenic
activation of lymphocytes (Taylor et al., 1971; Greaves et al., 1972).
Since the phenomenon of capping was originally described in 1971
by Taylor et al. on B lymphocytes in suspension, its relation to cell
motility and the endocytic cycle has been studied in a variety of
substrate-attached mononuclear cells (dePetris and Rff, 1972; Edidin
and Weiss, 1972; Vasilieu et al., 1976).

We investigated the

processing of con A-receptor complexes by osteoclasts in culture,
using con A-FITC to evaluate the redistribution of cell-bound con A
via epifluorescence microscopy and using con A-ferritin to determine
whether the lectin-receptor complexes are internalized via electron
microscopy.

The results demonstrate that redistribution and

endocytosis of con A-receptor complexes occurs within 30 minutes.

In

comparison to control osteoclasts that exhibit a fluorescent pattern
which is evenly distributed over the entire cell surface, after 15
minutes the fluorescence is localized to the membrane overlying the
central, nuclear region of the substrate-attached osteoclasts.

The

membrane peripheral to the nuclear region and membrane specializations
such as filopodia and lamellipodia were cleared of the fluorescent
label.

The redistribution of membrane-bound con A-FITC on

substrate-attached osteoclasts is similar to the movement of con AFITC on substrate-attached epithelial cells and fibroblasts described
by Vasilieu et al. (1976).

Electron microscopy of con A-ferritin
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treated osteoclasts revealed active endocytosis of the con A-receptor
complexes.

The ferritin label is concentrated in coated pits and in

tubular invaginations of the cell surface (fig. 2).

The tubular

vaginations found along some areas of the membrane form a system of
canaliculi that are continuous with the cell surface.

These tubular

invaginations are membrane specializations that form in response to
the binding and processing of con A, since they are absent in control
osteoclasts.

The internalization of con A may be an important event

in altering osteoclastic activity by mediating intracellular
mechanisms involved in the bone resorbing process.

Our findings

confirm the hypothesis that cell-bound con A can alter the structure
and activity of osteoclast membrane components in a manner similar to
that observed in some mononuclear cell cultures.

The redistribution

and endocytosis of con A-receptor complexes may represent a general
mechanism that is used by the osteoclast to process other endogenous
mediators of physiological function that directly bind to specific
membrane receptors.
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Fig. 1.

The percent of

45

Ca released at 24 hour intervals in

cultures of live calvarial explants versus devitalized
bone.

Live bone percent release: 24 hr= 4.7

48 hr • 8.2

± 0.5;

percent release:
72 hr • 3.1

+ 0.4.

72 hr

=

11.2 + 0.6.

± 0.3;

Dead bone

24 hr= 1.3 + 0.3; 48 hr= 2.2 + 0.2;
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Fig. 2.

Diagram showing some of the general events that occur
as a part of the endocytic mechanism following ligand
binding to specific surface receptors (right side of
broken line).

To the left are the membrane

specializations (tubular invaginations) that we
demonstrated on the surface of osteoclasts processing
cell-bound con A in vitro.
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Appendix to Chapter III
Discussion with Reviewers
T.J. Chambers: The authors should give some idea of the counts per
minute upon which their bone resorption assay figures are based.
S.C. Harks: The calcium-45 release data might be even more
significant if younger (newborn vs. 7 day old) rats and higher doses
(50-100 vs. 40 pCi) of calcium-45 were used. This would have made the
assay even more sensitive.
Authors: The data presented in Table 1 demonstrates some typical
values of radioactivity in counts per minute (cpm) generated from a
200 pl sample of tissue culture supernatant at 48 hours. The value
generated by a treated calvarial half is shown above the value
generated by the corresponding control half. Values for two calvarial
samples at each of the four concentrations of con A are ~hown. The
4 Ca bone
relatively high counts validate the sensitivity of our
release assay.
T.J. Chambers: What is the contribution of con A toxicity to
osteoclastic inhibition as demonstrated in this paper?
H.H. Hiller: How do you propose to distinguish between inhibition of
cytotoxicity at high concentrations of con A?
Authors: To determine whether the decrease in bone resorption at 50
pg/ml con A is due to con A induced inhibition of osteoclastic
activity or whether this high conczgtration is merely cytotoxic to
osteoclasts, we conducted another
Ca bone release assay. The
experimental protocol was identical to that which has already been
described in the text, with the exception that the media containing
con A was removed from the treated wells after 12 hours. These wells
were then rinsed and replenished with fresh media in the absence of
any con A. After 12 c~urs of incubation in 50 pg/ml con A, the
decreased release of
Ca from treated calvarial halves was
significantly different from that of control calvarial halves (fig.
1). 24 hours after con A was removed, the mean T/C ratio returned to
1.0 and this reversal continued at 48 hours (fig. 11). We also took a
sample 120 hours after con A removal and this preliminary data
suggests that we have a rebound effect on bone resorption. This
result showing that the decrease in bone resorption at 50 pg/ml is

183
reversible, indicates that con A is inhibitory rather than cytotoxic
to osteoclasts at this concentration.
45
S.C. Marks: The significance of the differences between
Ca release
at the lowest concentration of con A and the concentration {2.0 µg/ml)
with peak mitogenic activity is puzzling. That the former is higher
than the latter sugget5s that lymphokine production is probably not
involved in elevated
Ca release.

Authors: We agree with this conclusion and furthermore evaluated the
calvarial samples to determine the extent of cells present in the
culture system that could produce lymphokines. The calvarial samples
mere digested with collagenase and the cellular pools evaluated for T
lymphocytes, B lymphocytes, monocytes and macrophages, utilizing
fluorescence microscopy and fluorescein-conjugated antibodies directed
against specific cell surface markers. The calvarial system did not
contain enough cells to produce significant amounts of lymphokines.
T.J. Chambers: The bidirectional effect of con A suggests that there
may be both a direct and an indirect effect on osteoclastic activity.
Have you tested these possibilities using isolated osteoclasts? Has
anyone reported an effect of con A on osteoblast activity?
Authors: We have been unable to isolate a homogeneous population of
osteoclasts which could be tested in vitro. The osteoclast isolate
always contains mononuclear cells which may include lymphocytes and
osteoblasts, both of which are known to be able to influence
osteoclasts. We plan to evaluate the effelts of con A on osteoblast
activity by monitoring such parameters as H-proline incorporation,
alkaline phosphatase levels and cAMP levels.
R.S. Molday: Have you studied the effect of con A concentration on
the density and distribution of binding sites using the hemocyanin
method?
Authors: We have only looked at con A binding at the concentration of
100 pg/ml. The hemocyanin particles appear densely packed at this
concentration and may be causing steric hindrance. The density and
distribution of binding sites at different concentrations of con A
should be studied using a smaller marker and a TEM as well as an SEM
evaluation.
S.C. Marks:

What is the functional significance of con A binding?
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That a lectin would bind to the surface of an animal cell might not be
surprising. That this represents some specific receptor site remains
to be determined. We know of no evidence that these cells encounter
con A in vivo. Therefore, other than the fact that certain
carbohydrate moieties appear to be uniformly distributed on the
external surface of osteoclasts and osteoblasts, what does con A
binding mean? Can one make a case for its physiological significance
in bone?
Authors: We are using lectin binding and its stimulatory and/or
inhibitory effects as a model system for osteoclasts, much the same as
other investigators have used lectins to activate lymphocytes and
initiate their proliferation. Although the activation may be quite
non-specific, the way in which the lectin is handled by the cell,
i.e., the possible redistribution and endocytosis of binding sites,
may give some insight into the mechanisms by which physiologically
active substances exert their effects on bone cells.
H.H. Hiller: What are those fibrous structures associated with the
osteoblasts and would you comment on the apparent association of con
A-hemocyanin with them?
Authors: The fibrous structures are collagen fibrils. The con
A-hemocyanin is binding to the mannosyl and glucosyl residues of the
glycosaminoglycans associated with the collagen.
S.C. Harks: Is it possible that reduced calcium-45 release observed
with high doses of con A is caused by activation of the calcitonin
receptors through a local distortion of the osteoclast membrane by the
high density binding of con A? If so, one might not be surprised if a
measurement of bone formation at this dose were also affected.
Authors: We plan to investigate the fate of the con A binding sites
at various time intervals after treatment with the lectin. If the
binding sites demonstrate redistribution, then this movement may cause
the local distortion that you suggest. We are going to evaluate
osteoblastic activity at Jll of the concentrations originally tested
via the incorporation of H-proline.

H.H. Hiller:

How do you imagine that con A stimulates
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Ca release?

Authors: In order to approach this question we have to study the fate
of the con A-binding site complexes at various time intervals after
treatment. Is there redistribution of plasma membrane components; is
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the con A internalized by the bone cells; and is this internalization
necessary for stimulatfon?
R.S. Molday: In control labeling experiments, o(-methyl mannoside was
successfully used to reverse the labeling of cells with con A. Why
doesn't the hemocyanin also compete with the cell binding sites and
cause the con A to dissociate?
Authors: o(-methyl mannoside competes for the same sites by which con
A binds to cell surface macromolecules. Since Q('.~methyl mannoside has
a much greater affinity than cell surface glucosyl and mannosyl
residues for the same sites on the con A molecule, con A dissociates
from the cell surface when a-methyl mannoside is present in the
culture media. Hemocyanin, on the other hand, binds to sugar residues
on the con A molecule which are structurally different than those
involved in cell surface binding and, therefore, does not compete with
cell surface binding sites.
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Table 1

45ca Bone Release Assay
CPM at 48 Hours

con A (o. l µg/ml)

2550*

1922

con A (2.0 µg/ml)

2007

1471

---------------·
--------------------------------------control
1867
1533
-----------------------------------------------------·
control
1823
1569
con A ( 50 µg/ml)
~-------------------------

control

1219

----------------------------1948
1655

con A (100 µg/ml)
~-------------------------

control

1056

1165

1153

----------------------------2066
2149

I
*counts per minute generated from a 200 µl
sample of tissue culture supernatant
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Fig. 1.

Reversal of con A-mediated inhibition of bone resorption.
The mean T/C ratio is plotted on the y-axis and the time of
sampling on the x-axis. The numbers in parentheses
represents the time of sampling following con A removal
(indicated by arrow), whereas the number above represents
the totf! time in culture following the 24 hour washout of
labile
Ca.

188

1. 5
1. 4
1.3

con A
removed

1.2

·-0cu

1.1

~

a:

1.0

0
.........
I-

0.9

0.8

0.7
0.6
\

....-~~...--~~~~~....-~~~~~....------\\

12

36

60

( 2 4)

(48)

Time (hours}

I

132
( 120)

APPENDIX B

190

45
This appendix supplements the data presented in Chapter IV.
ca
bone release assays were conducted to determine the effect of wheat
germ agglutinin (WGA), soybean agglutinin (SBA) and peanut agglutinin
(PNA) on bone resorption. The data presented in Chapter IV only
includes the treated/control (T/C) ratios !or each lectin at a
4
concentration of 50 µg/ml. However, the
Ca bone release assays were
conducted at 2 or more concentrations for each of the lectins tested.
The following table lists the mean T/C ratios at 24, 48 and 72 hours
for all concentrations tested. The T/C ratios were compared to the
control/control (C/C) ratio obtained from the control release assay to
determine whether the observed changes in bone resorption were
significantly different. Significance was evaluated by a two-tailed
Student t-test for the difference between two means.

Table 1

Effects of various lectins on bone resorption
T/C ratios

Lectin

WGA

SBA

PNA

Concentration

(µ

g/ml )

24 hr.

48 hr.

72 hr.

0.1

1.08 ± .06

1.06 ± .04

1.09

1.0

1. 03 ± . 05

1.05 ± .04

10

1.06 ± .06
1.01 ± .09

0.95 ± .06

o. 95 ± .09

50

0.95±.09

*0.84 ± .05

*O. 71 ± .04

50

0. 98 ± .06

0.96±.07

0.97

100

1.00 ± .04

0.98 ± .02

0.97 ± .03

1.0

1.00 ± .03

1.01 ± .02

1. 01 ± . 06

10

1.03 ± .03

0.96 ± .06

1.01 ± .05

50

1.01 ± .08

0.97 ± .01

0. 94 ± .06

* Significantly different from control assay (p

:t

±

.05

.06

.......
.......

ID

<

.001)
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